Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	structural constituent of nuclear pore	TPR POM121C POM121 POM121B	2.54e-05	25	139	4	GO:0017056
GeneOntologyMolecularFunction	transcription factor binding	SETD1A SP1 HDAC6 ZNF618 SRC GCM1 CRTC1 FOXA3 RXRA DDX5 BPTF NCOR1 ARNT MED12L TBX20 MTDH	7.17e-05	753	139	16	GO:0008134
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	TNIK SEMA6C KIF13B SEMA4B HDAC6 FN1 ANK3 ABI3BP CAMK2B CLASP2 TECTA ADARB1 DSCAML1 OTX2 EFNB2 SIPA1L1 KIAA1755 IGSF9 TBR1 PARD3	2.98e-07	748	145	20	GO:0048667
GeneOntologyBiologicalProcess	cell projection morphogenesis	TNIK SEMA6C KIF13B SEMA4B HDAC6 FN1 ANK3 ABI3BP CAMK2B SRC CLASP2 ADARB1 DSCAML1 OTX2 EFNB2 SIPA1L1 KIAA1755 IGSF9 TBR1 PARD3 MUC3A	3.35e-07	826	145	21	GO:0048858
GeneOntologyBiologicalProcess	cell morphogenesis	TNIK SEMA6C KIF13B SEMA4B HDAC6 FN1 ANK3 ABI3BP CAMK2B SIPA1L3 SRC CLASP2 TECTA ADARB1 DSCAML1 OTX2 EFNB2 SIPA1L1 KIAA1755 LRP6 IGSF9 TBR1 PARD3 MUC3A ZMYM6	8.64e-07	1194	145	25	GO:0000902
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	TNIK SEMA6C KIF13B SEMA4B HDAC6 FN1 ANK3 ABI3BP CAMK2B SRC CLASP2 ADARB1 DSCAML1 OTX2 EFNB2 SIPA1L1 KIAA1755 IGSF9 TBR1 PARD3	1.23e-06	819	145	20	GO:0120039
GeneOntologyBiologicalProcess	axonogenesis	SEMA6C KIF13B SEMA4B HDAC6 FN1 ANK3 CLASP2 ADARB1 DSCAML1 OTX2 EFNB2 SIPA1L1 KIAA1755 IGSF9 TBR1 PARD3	2.47e-06	566	145	16	GO:0007409
GeneOntologyBiologicalProcess	neuron projection morphogenesis	TNIK SEMA6C KIF13B SEMA4B HDAC6 FN1 ANK3 ABI3BP CAMK2B CLASP2 ADARB1 DSCAML1 OTX2 EFNB2 SIPA1L1 KIAA1755 IGSF9 TBR1 PARD3	3.61e-06	802	145	19	GO:0048812
GeneOntologyBiologicalProcess	nuclear pore organization	TPR POM121C POM121 POM121B	6.64e-06	18	145	4	GO:0006999
GeneOntologyBiologicalProcess	immunoglobulin production	IGKV1-8 IGLV8-61 IGLV3-27 IGLV3-25 IGLV3-22 IGLV3-21 IGLV3-9 IGLV3-1 PTPRC IGKV6D-41	8.18e-06	241	145	10	GO:0002377
GeneOntologyBiologicalProcess	neuron development	TNIK SEMA6C KIF13B SEMA4B HDAC6 FN1 ANK3 ABI3BP CAMK2B CRTC1 CLASP2 TECTA NPHP4 ADARB1 DSCAML1 FBXO38 OTX2 CCDC88A TENM4 EFNB2 SIPA1L1 KIAA1755 LRP6 IGSF9 TBR1 PARD3	1.02e-05	1463	145	26	GO:0048666
GeneOntologyBiologicalProcess	neuron projection development	TNIK SEMA6C KIF13B SEMA4B HDAC6 FN1 ANK3 ABI3BP CAMK2B CRTC1 CLASP2 TECTA ADARB1 DSCAML1 FBXO38 OTX2 CCDC88A EFNB2 SIPA1L1 KIAA1755 LRP6 IGSF9 TBR1 PARD3	1.04e-05	1285	145	24	GO:0031175
GeneOntologyBiologicalProcess	axon development	SEMA6C KIF13B SEMA4B HDAC6 FN1 ANK3 CLASP2 ADARB1 DSCAML1 OTX2 EFNB2 SIPA1L1 KIAA1755 IGSF9 TBR1 PARD3	1.21e-05	642	145	16	GO:0061564
GeneOntologyBiologicalProcess	axon guidance	SEMA6C SEMA4B HDAC6 ANK3 DSCAML1 OTX2 EFNB2 KIAA1755 IGSF9 TBR1	3.47e-05	285	145	10	GO:0007411
GeneOntologyBiologicalProcess	neuron projection guidance	SEMA6C SEMA4B HDAC6 ANK3 DSCAML1 OTX2 EFNB2 KIAA1755 IGSF9 TBR1	3.57e-05	286	145	10	GO:0097485
GeneOntologyBiologicalProcess	regulation of anatomical structure morphogenesis	TNIK SEMA6C KIF13B SP1 HDAC6 FN1 ABI3BP CAMK2B SRC CLASP2 RXRA EPN2 OTX2 TENM4 EFNB2 PIK3CD SIPA1L1 LRP6 MTDH ZMYM6	7.88e-05	1090	145	20	GO:0022603
GeneOntologyBiologicalProcess	regulation of neuron projection development	TNIK SEMA6C KIF13B HDAC6 FN1 ABI3BP CAMK2B CRTC1 FBXO38 CCDC88A EFNB2 SIPA1L1 LRP6 TBR1	1.08e-04	612	145	14	GO:0010975
GeneOntologyBiologicalProcess	regulation of toll-like receptor 3 signaling pathway	UBQLN1 SRC PELI1	1.17e-04	14	145	3	GO:0034139
GeneOntologyBiologicalProcess	production of molecular mediator of immune response	IGKV1-8 IGLV8-61 IGLV3-27 IGLV3-25 IGLV3-22 IGLV3-21 IGLV3-9 IGLV3-1 PTPRC IGKV6D-41 CD96	1.35e-04	403	145	11	GO:0002440
GeneOntologyBiologicalProcess	maintenance of protein location in membrane	ANK3 CCDC88A	1.47e-04	3	145	2	GO:0072658
GeneOntologyBiologicalProcess	maintenance of protein location in plasma membrane	ANK3 CCDC88A	1.47e-04	3	145	2	GO:0072660
GeneOntologyBiologicalProcess	nucleus organization	TPR PHF8 POM121C POM121 AGFG1 POM121B TOR1AIP1	2.03e-04	170	145	7	GO:0006997
GeneOntologyCellularComponent	immunoglobulin complex	IGKV1-8 IGLV8-61 IGLV3-27 IGLV3-25 IGLV3-22 IGLV3-21 IGLV3-9 IGLV3-1 IGHA1 IGKV6D-41	2.49e-07	166	145	10	GO:0019814
GeneOntologyCellularComponent	Golgi lumen	MUC19 MUC16 ABCC5 MUC12 MUC3A MUC5AC	1.13e-04	109	145	6	GO:0005796
HumanPheno	Autistic behavior	FLG SETD1A HIVEP2 ANK3 IFT172 CAMK2B BCORL1 HECTD4 TNRC6B RFX7 USF3 OTX2 SMC3 UBAP2L MED12L ANKRD17 TBR1 ZNF292	7.04e-05	678	52	18	HP:0000729
HumanPheno	Thin vermilion border	TPR HIVEP2 TNRC6B RFX7 ADARB1 DDB1 BPTF SMC3 UBAP2L PIK3CD MED12L ANKRD17 CD96 ZNF292	7.23e-05	433	52	14	HP:0000233
HumanPheno	Diagnostic behavioral phenotype	FLG SETD1A DRD3 HIVEP2 ANK3 IFT172 CAMK2B BCORL1 HECTD4 TNRC6B RFX7 USF3 OTX2 SMC3 UBAP2L MED12L ANKRD17 TBR1 ZNF292	7.36e-05	747	52	19	HP:0025783
HumanPheno	Medial flaring of the eyebrow	HIVEP2 IFT172 HECTD4 PHF8 DDB1 RUSC2 BPTF SMC3 UBAP2L ZNF292	7.99e-05	228	52	10	HP:0010747
HumanPheno	Thin upper lip vermilion	TPR HIVEP2 TNRC6B RFX7 ADARB1 DDB1 BPTF SMC3 UBAP2L MED12L ANKRD17 ZNF292	1.13e-04	339	52	12	HP:0000219
HumanPheno	Thin lips	TPR HIVEP2 TNRC6B RFX7 ADARB1 DDB1 BPTF SMC3 UBAP2L MED12L ANKRD17 ZNF292	1.13e-04	339	52	12	HP:0000213
HumanPheno	Synophrys	HIVEP2 HECTD4 PHF8 DDB1 RUSC2 BPTF SMC3 UBAP2L ZNF292	1.29e-04	195	52	9	HP:0000664
HumanPheno	Facial hypertrichosis	HIVEP2 HECTD4 PHF8 DDB1 RUSC2 BPTF SMC3 UBAP2L ZNF292	1.97e-04	206	52	9	HP:0002219
HumanPheno	Long fingers	TPR HIVEP2 BCORL1 HECTD4 PHF8 KMT2E RFX7 RUSC2 CCDC88A MED12L TBR1	2.01e-04	306	52	11	HP:0100807
HumanPheno	Disinhibition	TNIK FLG SETD1A HIVEP2 ANK3 CAMK2B BCORL1 HECTD4 TNRC6B KMT2E RFX7 DDB1 RUSC2 BPTF SMC3 UBAP2L MED12L ANKRD17 ZNF292	2.12e-04	807	52	19	HP:0000734
HumanPheno	Inappropriate behavior	TNIK FLG SETD1A HIVEP2 ANK3 CAMK2B BCORL1 HECTD4 TNRC6B KMT2E RFX7 DDB1 RUSC2 BPTF SMC3 UBAP2L MED12L ANKRD17 ZNF292	2.12e-04	807	52	19	HP:0000719
HumanPheno	Abnormal response to social norms	TNIK FLG SETD1A HIVEP2 ANK3 CAMK2B BCORL1 HECTD4 TNRC6B KMT2E RFX7 DDB1 RUSC2 BPTF SMC3 UBAP2L MED12L ANKRD17 ZNF292	2.12e-04	807	52	19	HP:5200123
HumanPheno	Social disinhibition	TNIK FLG SETD1A HIVEP2 ANK3 CAMK2B BCORL1 HECTD4 TNRC6B KMT2E RFX7 DDB1 RUSC2 BPTF SMC3 UBAP2L MED12L ANKRD17 ZNF292	2.12e-04	807	52	19	HP:5200029
HumanPheno	Slanting of the palpebral fissure	SETD1A HIVEP2 IFT172 BCORL1 HECTD4 TNRC6B PHF8 KMT2E RFX7 ADARB1 DDB1 BPTF UBAP2L MED12L ANKRD17 TBR1 CD96 ZNF292	2.18e-04	739	52	18	HP:0200006
HumanPheno	Deeply set eye	TPR SETD1A CAMK2B SRC KMT2E BPTF UBAP2L PIK3CD MED12L ANKRD17	2.86e-04	266	52	10	HP:0000490
HumanPheno	Abnormal upper lip morphology	TPR SETD1A HIVEP2 HDAC6 IFT172 HECTD4 TNRC6B PHF8 RFX7 ADARB1 DDB1 BPTF OTX2 SMC3 ARHGAP31 UBAP2L MED12L ANKRD17 TBR1 CD96 ZNF292	3.25e-04	980	52	21	HP:0000177
HumanPheno	Abnormal social development	TNIK FLG SETD1A HIVEP2 ANK3 CAMK2B BCORL1 HECTD4 TNRC6B KMT2E RFX7 DDB1 RUSC2 BPTF SMC3 UBAP2L MED12L ANKRD17 TBR1 ZNF292	3.37e-04	908	52	20	HP:0025732
Domain	C8	MUC19 TECTA MUC5AC	6.61e-05	12	128	3	PF08742
Domain	TIL	MUC19 TECTA MUC5AC	6.61e-05	12	128	3	PF01826
Domain	Unchr_dom_Cys-rich	MUC19 TECTA MUC5AC	8.55e-05	13	128	3	IPR014853
Domain	C8	MUC19 TECTA MUC5AC	8.55e-05	13	128	3	SM00832
Domain	TIL_dom	MUC19 TECTA MUC5AC	1.08e-04	14	128	3	IPR002919
Domain	SPAR_C	SIPA1L3 SIPA1L1	1.39e-04	3	128	2	PF11881
Domain	SIPA1L_C	SIPA1L3 SIPA1L1	1.39e-04	3	128	2	IPR021818
Domain	VWF_type-D	MUC19 TECTA MUC5AC	1.65e-04	16	128	3	IPR001846
Domain	VWFD	MUC19 TECTA MUC5AC	1.65e-04	16	128	3	PS51233
Domain	VWD	MUC19 TECTA MUC5AC	1.65e-04	16	128	3	SM00216
Domain	VWD	MUC19 TECTA MUC5AC	1.65e-04	16	128	3	PF00094
Domain	UIM	EPN2 ANKIB1 DNAJB2	2.38e-04	18	128	3	PF02809
Domain	VWC_out	MUC19 TECTA MUC5AC	2.81e-04	19	128	3	SM00215
Domain	UIM	EPN2 ANKIB1 DNAJB2	3.82e-04	21	128	3	SM00726
Domain	NIDO_dom	TECTA SNED1	4.60e-04	5	128	2	IPR003886
Domain	NIDO	TECTA SNED1	4.60e-04	5	128	2	SM00539
Domain	NIDO	TECTA SNED1	4.60e-04	5	128	2	PF06119
Domain	NIDO	TECTA SNED1	4.60e-04	5	128	2	PS51220
Domain	SEA	MUC16 MUC12 MUC3A	5.04e-04	23	128	3	PS50024
Domain	SEA_dom	MUC16 MUC12 MUC3A	5.04e-04	23	128	3	IPR000082
Domain	UIM	EPN2 ANKIB1 DNAJB2	5.73e-04	24	128	3	PS50330
Domain	UIM_dom	EPN2 ANKIB1 DNAJB2	6.48e-04	25	128	3	IPR003903
Domain	fn3	FN1 ABI3BP DSCAML1 SNED1 PTPRC IGSF9	8.81e-04	162	128	6	PF00041
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC16 MUC12 MUC3A MUC5AC	3.75e-06	16	98	4	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC16 MUC12 MUC3A MUC5AC	4.88e-06	17	98	4	M27412
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC12 MUC3A MUC5AC	1.76e-05	23	98	4	M556
Pathway	REACTOME_GENE_SILENCING_BY_RNA	TPR TNRC6B POM121C POM121 POM121B	2.19e-05	49	98	5	MM14837
Pathway	REACTOME_DECTIN_2_FAMILY	MUC16 MUC12 MUC3A MUC5AC	2.92e-05	26	98	4	M27483
Pathway	REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS	TPR HDAC6 CAMK2B POM121C POM121 POM121B	4.26e-05	92	98	6	MM14951
Pathway	REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS	SRC ADCY9 IGLV3-27 IGLV3-25 IGLV3-21 IGLV3-1	5.11e-05	95	98	6	M29842
Pathway	REACTOME_FCGR_ACTIVATION	SRC IGLV3-27 IGLV3-25 IGLV3-21 IGLV3-1	1.16e-04	69	98	5	M27108
Pathway	REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA	IGLV3-27 IGLV3-25 IGLV3-21 IGLV3-1 IGHA1	1.16e-04	69	98	5	M27150
Pathway	REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY	TPR POM121C POM121 POM121B	1.66e-04	40	98	4	MM14945
Pathway	REACTOME_SUMOYLATION	TPR POM121C RXRA DDX5 POM121 SMC3 POM121B	1.74e-04	169	98	7	MM14919
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS	TPR POM121C POM121 POM121B	1.83e-04	41	98	4	MM15200
Pathway	REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS	TPR POM121C POM121 POM121B	2.01e-04	42	98	4	MM15039
Pathway	REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA	TPR POM121C POM121 POM121B	2.20e-04	43	98	4	MM14609
Pathway	REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS	TPR POM121C POM121 SMC3 POM121B	2.93e-04	84	98	5	MM14929
Pathway	REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS	TPR POM121C POM121 POM121B	3.11e-04	47	98	4	MM14939
Pathway	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	IGLV3-27 IGLV3-25 IGLV3-21 IGLV3-1 PIK3CD	3.27e-04	86	98	5	M601
Pathway	REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION	SRC ADCY9 IGLV3-27 IGLV3-25 IGLV3-21 IGLV3-1	3.39e-04	134	98	6	M29840
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC19 MUC16 MUC5AC	3.96e-04	21	98	3	MM15706
Pathway	REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS	TPR POM121C POM121 POM121B	3.96e-04	50	98	4	MM14610
Pathway	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	FN1 SRC IGLV3-27 IGLV3-25 IGLV3-21 IGLV3-1 IGHA1	4.04e-04	194	98	7	M16312
Pathway	REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS	TPR POM121C POM121 POM121B	4.27e-04	51	98	4	MM15151
Pathway	REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS	PERM1 CRTC1 RXRA NCOR1	5.71e-04	55	98	4	M27145
Pathway	REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN	TPR POM121C POM121 POM121B	5.71e-04	55	98	4	MM14917
Pathway	REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION	POM121C POM121 POM121B	5.93e-04	24	98	3	MM15658
Pathway	REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS	IGLV3-27 IGLV3-25 IGLV3-21 IGLV3-1 IGHA1	5.97e-04	98	98	5	M27152
Pathway	REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS	TPR HDAC6 CAMK2B POM121C POM121	6.85e-04	101	98	5	M27253
Pathway	REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS	TPR POM121C POM121 POM121B	6.99e-04	58	98	4	MM15149
Pathway	REACTOME_SNRNP_ASSEMBLY	TPR POM121C POM121 POM121B	6.99e-04	58	98	4	MM14736
Pathway	REACTOME_CD22_MEDIATED_BCR_REGULATION	IGLV3-27 IGLV3-25 IGLV3-21 IGLV3-1	8.46e-04	61	98	4	M27581
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC16 MUC12 MUC3A MUC5AC	9.00e-04	62	98	4	M546
Pathway	WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING	FN1 SRC PIK3CD	9.41e-04	28	98	3	M39572
Pathway	REACTOME_TGFBR3_EXPRESSION	SP1 TNRC6B RXRA	9.41e-04	28	98	3	M48253
Pathway	REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS	TPR POM121C POM121 POM121B	1.07e-03	65	98	4	MM15147
Pubmed	A human MAP kinase interactome.	TPR SP1 HIVEP2 ANK3 ABI3BP SRC CRTC1 MUC12 POM121C USF3 CCDC88A POM121 SMC3 ARHGAP31 AGFG1 NAV2 ANKRD17	2.84e-11	486	146	17	20936779
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TNIK TPR KIF13B CACNA1E ANK3 ZNF618 CAMK2B SIPA1L3 SRC HECTD4 TNRC6B CLASP2 ARHGAP39 BCL9 DDB1 NCOR1 CCDC88A UBAP2L SIPA1L1 FBXO41 ANKRD17 PARD3	1.15e-10	963	146	22	28671696
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	KIF13B PALD1 FLG ANK3 IFT172 CAMK2B SAV1 AMBRA1 CRTC1 FAM117B CLASP2 RAB11FIP1 POM121C NPHP4 DDX5 EPN2 CCDC88A POM121 SMC3 SIPA1L1 TBR1 PARD3 CDC27 MUC5AC FOXK1	2.82e-10	1321	146	25	27173435
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	TPR PALD1 HDAC6 ANK3 TNRC6B ABCC5 ARHGAP39 DDB1 ADCY9 DDX5 CCDC88A SMC3 UBAP2L LRP6 ANKRD17 PARD3 EIF2A CDC27	1.23e-09	708	146	18	39231216
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	HIVEP2 ANK3 CAMK2B SIPA1L3 SRC HECTD4 TNRC6B FAM117B CLASP2 ARHGAP39 TECTA TEP1 SLC10A7 ADARB1 RXRA BPTF CFAP20DC USF3 EFNB2 UBAP2L ANKIB1 ANKRD17 IGSF9 LSM14A PARD3	3.23e-09	1489	146	25	28611215
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SEMA6C SETD1A HECTD4 AMBRA1 CRTC1 ADCY9 CCDC88A ARHGAP31 MED12L ANKIB1 FBXO41 NAV2 ANKRD17 IGSF9 HERC4	7.58e-09	529	146	15	14621295
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC19 MUC16 MUC12 MUC3A MUC5AC	9.98e-09	18	146	5	18834073
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	CACNA1E FN1 IFT172 TNRC6B CLASP2 WASHC2A DDX5 NCOR1 TENM4 UBAP2L SIPA1L1 LSM14A PARD3 MTDH	1.52e-08	475	146	14	31040226
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	KIF13B HIVEP2 SIPA1L3 CRTC1 FAM117B CLASP2 RAB11FIP1 RFX7 EPN2 RUSC2 CCDC88A SIPA1L1 AGFG1 NAV2 ANKRD17 PARD3 ZNF598 FOXK1	2.51e-08	861	146	18	36931259
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TPR SP1 HDAC6 ARHGAP39 PHF8 BCL9 RFX7 ADARB1 FBXO38 BPTF NCOR1 PTPRC PAPOLA UBAP2L SIPA1L1 ANKRD17 PARD3	3.11e-08	774	146	17	15302935
Pubmed	Human transcription factor protein interaction networks.	FLG SETD1A SP1 BCORL1 TNRC6B GCM1 PHF8 BCL9 RFX7 POM121C WASHC2A DDB1 RXRA BPTF NCOR1 ARNT SMC3 UBAP2L LRP6 ANKRD17 LSM14A TBR1 FOXK1	3.23e-08	1429	146	23	35140242
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	CACNA1E SP1 ABCC5 PERM1 KMT2E NCOR1 UBAP2L ANKIB1 DNAJB2 ZNF292	6.00e-08	233	146	10	37704626
Pubmed	POM121 inhibits the macrophage inflammatory response by impacting NF-κB P65 nuclear accumulation.	POM121C POM121 POM121B	7.25e-08	3	146	3	30802453
Pubmed	Nucleoporin POM121 signals TFEB-mediated autophagy via activation of SIGMAR1/sigma-1 receptor chaperone by pridopidine.	POM121C POM121 POM121B	7.25e-08	3	146	3	35507432
Pubmed	Acute promyelocytic leukemia cell line AP-1060 established as a cytokine-dependent culture from a patient clinically resistant to all-trans retinoic acid and arsenic trioxide.	SRC RXRA NCOR1	7.25e-08	3	146	3	15116119
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	TPR KIF13B USP45 HDAC6 FN1 ANK3 CRTC1 CLASP2 WASHC2A PTPRC PAPOLA UBAP2L PIK3CD SIPA1L1 ANKRD17 PARD3 CDC27 HERC4 MTDH	1.57e-07	1084	146	19	11544199
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KIF13B SEMA4B SH3TC2 SYNM ZNF618 SIPA1L3 ARHGAP39 POM121C NPHP4 EPN2 USF3 POM121 POM121B	1.83e-07	493	146	13	15368895
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	ANK3 SYNM TNRC6B POM121C DDX5 CCDC88A POM121 PARD3 TOR1AIP1 MTDH	1.85e-07	263	146	10	34702444
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	FN1 ANK3 SYNM SRC MUC16 TNRC6B ABCC5 CLASP2 NDRG3 ADCY9 NCOR1 CCDC88A EFNB2 PARD3 TOR1AIP1 MTDH	1.94e-07	777	146	16	35844135
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SEMA6C PALD1 SETD1A SEMA4B HIVEP2 SIPA1L3 HECTD4 AMBRA1 CLASP2 BCL9 TEP1 POM121C NPHP4 WASHC2A ADCY9 NCOR1 PIK3CD NAV2 FOXK1	2.11e-07	1105	146	19	35748872
Pubmed	Prediction of the coding sequences of unidentified human genes. X. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	KIF13B HECTD4 CRTC1 CLASP2 NPHP4 POM121 ANKRD17	2.63e-07	102	146	7	9734811
Pubmed	Two distinct human POM121 genes: requirement for the formation of nuclear pore complexes.	POM121C POM121 POM121B	2.89e-07	4	146	3	17900573
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	SETD1A SP1 UBQLN1 ANK3 BCL9 KMT2E POM121C NCOR1 USF3 POM121 ARHGAP31 AGFG1	3.03e-07	430	146	12	35044719
Pubmed	Interaction network of human early embryonic transcription factors.	SETD1A HIVEP2 BCORL1 BCL9 RFX7 POM121C BPTF NCOR1 ARNT OTX2 FOXK1	3.08e-07	351	146	11	38297188
Pubmed	One-megabase sequence analysis of the human immunoglobulin lambda gene locus.	IGLV8-61 IGLV3-27 IGLV3-25 IGLV3-22 IGLV3-21 IGLV3-9 IGLV3-1	4.14e-07	109	146	7	9074928
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	TNIK TPR PALD1 TNRC6B POM121C DDB1 DDX5 PAPOLA UBAP2L AGFG1 ANKRD17 LSM14A EIF2A ZNF598 HERC4 TOR1AIP1 MTDH	4.43e-07	934	146	17	33916271
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	TNIK SIPA1L3 TNRC6B PHF8 DSCAML1 ADCY9 TENM4 SIPA1L1 NAV2	5.07e-07	225	146	9	12168954
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	MUC19 TNRC6B POM121C NCOR1 CCDC88A EIF2A ZNF292	9.40e-07	123	146	7	26912792
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	BCL9 BPTF NCOR1 SMC3 FOXK1 ZNF292	1.43e-06	83	146	6	28794006
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC19 MUC16 MUC5AC	1.44e-06	6	146	3	19110483
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	CACNA1E CAMK2B SRC ARHGAP39 ADCY9 EPN2 RUSC2 UBAP2L SIPA1L1 FBXO41	2.29e-06	347	146	10	17114649
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	TPR TNRC6B BCL9 POM121C DDX5 NCOR1 ARNT POM121 ANKRD17 TOR1AIP1 FOXK1	3.99e-06	457	146	11	32344865
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	TPR HDAC6 AMBRA1 CLASP2 DDB1 DDX5 CCDC88A SMC3 UBAP2L LSM14A ZNF598 MTDH	4.00e-06	551	146	12	34728620
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	HDAC6 ZNF618 AOX1 TNRC6B AMBRA1 PHF8 RAB11FIP1 TEP1 POM121C DDB1 ADCY9 BPTF SIPA1L1 ANKRD17 PARD3 CDC27 FOXK1	4.89e-06	1116	146	17	31753913
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	TPR UBQLN1 WWC3 SIPA1L3 TNRC6B CLASP2 RFX7 DDB1 RXRA DDX5 NCOR1 ARNT PAPOLA SMC3 SIPA1L1 ANKRD17 PARD3 ZNF598	5.30e-06	1247	146	18	27684187
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TNIK PALD1 IFT172 TNRC6B PHF8 WASHC2A RUSC2 TENM4 UBAP2L SIPA1L1	9.30e-06	407	146	10	12693553
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	SYNM SIPA1L3 TNRC6B NPHP4 NCOR1 ARHGAP31 SIPA1L1	1.35e-05	184	146	7	32908313
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	TNIK PALD1 SAV1 TNRC6B CLASP2 WASHC2A DDB1 ADCY9 PCDH17 CCDC88A AGFG1 POC5 TOR1AIP1	1.42e-05	733	146	13	34672954
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	KIF13B SETD1A PHF8 POM121C DDB1 BPTF NCOR1 PAPOLA FOXK1	1.50e-05	341	146	9	32971831
Pubmed	PAR3 and aPKC regulate Golgi organization through CLASP2 phosphorylation to generate cell polarity.	CLASP2 PARD3	1.75e-05	2	146	2	25518939
Pubmed	Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers.	MUC16 MUC5AC	1.75e-05	2	146	2	22220206
Pubmed	Cigarette smoke induces MUC5AC protein expression through the activation of Sp1.	SP1 MUC5AC	1.75e-05	2	146	2	22700966
Pubmed	Sipa1l3/SPAR3 is targeted to postsynaptic specializations and interacts with the Fezzin ProSAPiP1/Lzts3.	SIPA1L3 SIPA1L1	1.75e-05	2	146	2	26364583
Pubmed	Reduction of hepatitis C virus NS5A phosphorylation through its interaction with amphiphysin II.	AMPH SRC	1.75e-05	2	146	2	16139795
Pubmed	Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer.	MUC16 MUC5AC	1.75e-05	2	146	2	24722639
Pubmed	SP1-induced SNHG14 aggravates hypertrophic response in in vitro model of cardiac hypertrophy via up-regulation of PCDH17.	SP1 PCDH17	1.75e-05	2	146	2	32436661
Pubmed	Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis.	MUC16 MUC5AC	1.75e-05	2	146	2	18782111
Pubmed	Loss of polarity protein Par3 is mediated by transcription factor Sp1 in breast cancer.	SP1 PARD3	1.75e-05	2	146	2	34023783
Pubmed	Proteomic analysis of Girdin-interacting proteins in migrating new neurons in the postnatal mouse brain.	CLASP2 CCDC88A	1.75e-05	2	146	2	24211587
Pubmed	The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 binding.	SP1 ARNT	1.75e-05	2	146	2	16410262
Pubmed	Sp1 mediate hypoxia induced ephrinB2 expression via a hypoxia-inducible factor independent mechanism.	SP1 EFNB2	1.75e-05	2	146	2	19883626
Pubmed	Triiodothyronine represses MUC5AC expression by antagonizing Sp1 binding to its promoter in human bronchial epithelial HBE16 cells.	SP1 MUC5AC	1.75e-05	2	146	2	22500101
Pubmed	Peering through the pore: nuclear pore complex structure, assembly, and function.	TPR POM121C POM121 POM121B	1.97e-05	38	146	4	12791264
Pubmed	Paladin (X99384) is expressed in the vasculature and shifts from endothelial to vascular smooth muscle cells during mouse development.	PALD1 PTPRC EFNB2	2.01e-05	13	146	3	22354871
Pubmed	The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.	PALD1 SIPA1L3 TNRC6B RAB11FIP1 BCL9 POM121C NDRG3 POM121 EFNB2 SIPA1L1 AGFG1 LSM14A EIF2A ZNF598 MTDH	2.37e-05	1007	146	15	34597346
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	TNIK TPR AMPH ANK3 CAMK2B TNRC6B ARHGAP39 WASHC2A NDRG3 CCDC88A TENM4 UBAP2L SIPA1L1 FBXO41 DNAJB2 MTDH	2.54e-05	1139	146	16	36417873
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	TNIK CACNA1E AMPH ANK3 CAMK2B SRC ARHGAP39 SIPA1L1	2.65e-05	281	146	8	28706196
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	TNIK KIF13B SRC ABCC5 RAB11FIP1 NDRG3 ADCY9 EPN2 ARHGAP31 NAV2 PARD3	3.06e-05	569	146	11	30639242
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	TNIK SIPA1L3 TNRC6B CLASP2 WASHC2A CCDC88A SIPA1L1	3.06e-05	209	146	7	36779422
Pubmed	Limited expression of nuclear pore membrane glycoprotein 210 in cell lines and tissues suggests cell-type specific nuclear pores in metazoans.	POM121C POM121 POM121B	3.18e-05	15	146	3	14697343
Pubmed	Activation of C1r by proteolytic cleavage.	IGLV8-61 IGLV3-27 IGLV3-25 IGLV3-22	3.24e-05	43	146	4	1249422
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	TNIK HDAC6 CRTC1 CLASP2 RAB11FIP1 WASHC2A DDX5 RUSC2 CCDC88A UBAP2L AGFG1 LSM14A POC5 CDC27 FOXK1	3.35e-05	1038	146	15	26673895
Pubmed	A hypomorphic lsd1 allele results in heart development defects in mice.	FN1 CAMK2B LRP6	3.90e-05	16	146	3	23637775
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	TNIK SIPA1L3 TNRC6B ARHGAP39 SIPA1L1 FBXO41 ZNF598	4.01e-05	218	146	7	33378226
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	KIF13B CAMK2B BCORL1 WASHC2A DDX5 NCOR1 ARNT CCDC88A AGFG1 FOXK1 ZMYM6	4.12e-05	588	146	11	38580884
Pubmed	Functional proteomics mapping of a human signaling pathway.	UBQLN1 FN1 ANK3 DDB1 RXRA EPN2 NCOR1 ARNT PTPRC PAPOLA DNAJB2	4.31e-05	591	146	11	15231748
Pubmed	Physicochemical and functional characterization of the C1r subunit of the first complement component.	IGLV8-61 IGLV3-27 IGLV3-25 IGLV3-22	4.62e-05	47	146	4	814163
Pubmed	Recognition of immunoglobulins by Fcgamma receptors.	IGLV8-61 IGLV3-27 IGLV3-25 IGLV3-22	5.02e-05	48	146	4	11955599
Pubmed	Assessment of mucin-related gene alterations following treatment with rebamipide ophthalmic suspension in Sjögren's syndrome-associated dry eyes.	MUC16 MUC5AC	5.24e-05	3	146	2	33232357
Pubmed	Mapping of the mouse fibronectin gene (Fn-1) to chromosome 1: conservation of the Idh-1-Cryg-Fn-1 synteny group in mammals.	FN1 AOX1	5.24e-05	3	146	2	2895729
Pubmed	HIV-1 infection increases microRNAs that inhibit Dicer1, HRB and HIV-EP2, thereby reducing viral replication.	HIVEP2 AGFG1	5.24e-05	3	146	2	30682089
Pubmed	Interaction between the two ubiquitously expressed transcription factors NF-Y and Sp1.	SP1 RXRA	5.24e-05	3	146	2	10393239
Pubmed	Expression of mucin 3 and mucin 5AC in arthritic synovial tissue.	MUC3A MUC5AC	5.24e-05	3	146	2	18163520
Pubmed	Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis.	MUC16 MUC12	5.24e-05	3	146	2	26770020
Pubmed	Retinoic acid (RA) regulates 17beta-hydroxysteroid dehydrogenase type 2 expression in endometrium: interaction of RA receptors with specificity protein (SP) 1/SP3 for estradiol metabolism.	SP1 RXRA	5.24e-05	3	146	2	18270252
Pubmed	Molecular Insights into the Recruiting Between UCP2 and DDX5/UBAP2L in the Metabolic Plasticity of Non-Small-Cell Lung Cancer.	DDX5 UBAP2L	5.24e-05	3	146	2	34308648
Pubmed	RapGAPs in brain: multipurpose players in neuronal Rap signalling.	SIPA1L3 SIPA1L1	5.24e-05	3	146	2	20576033
Pubmed	Ambra1 spatially regulates Src activity and Src/FAK-mediated cancer cell invasion via trafficking networks.	SRC AMBRA1	5.24e-05	3	146	2	28362576
Pubmed	Regulation of constitutive gene expression through interactions of Sp1 protein with the nuclear aryl hydrocarbon receptor complex.	SP1 ARNT	5.24e-05	3	146	2	10471301
Pubmed	Involvement of aryl hydrocarbon receptor nuclear translocator in EGF-induced c-Jun/Sp1-mediated gene expression.	SP1 ARNT	5.24e-05	3	146	2	20508969
Pubmed	Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database.	TBR1 ZNF292	5.24e-05	3	146	2	25849321
Pubmed	KIF13B establishes a CAV1-enriched microdomain at the ciliary transition zone to promote Sonic hedgehog signalling.	KIF13B NPHP4	5.24e-05	3	146	2	28134340
Pubmed	MLL5, a histone modifying enzyme, regulates androgen receptor activity in prostate cancer cells by recruiting co-regulators, HCF1 and SET1.	SETD1A KMT2E	5.24e-05	3	146	2	33050986
Pubmed	T/B lineage choice occurs prior to intrathymic Notch signaling.	FN1 PTPRC	5.24e-05	3	146	2	15845899
Pubmed	Fibronectin protects lung cancer cells against docetaxel-induced apoptosis by promoting Src and caspase-8 phosphorylation.	FN1 SRC	5.24e-05	3	146	2	27465556
Pubmed	Transcriptional activation of the murine Muc5ac mucin gene in epithelial cancer cells by TGF-beta/Smad4 signalling pathway is potentiated by Sp1.	SP1 MUC5AC	5.24e-05	3	146	2	14570593
Pubmed	Sequence and evolution of the human germline V lambda repertoire.	IGLV8-61 IGLV3-25 IGLV3-22 IGLV3-9	5.45e-05	49	146	4	8951372
Pubmed	A Non-catalytic Function of SETD1A Regulates Cyclin K and the DNA Damage Response.	SETD1A DDX5 SMC3	5.65e-05	18	146	3	29474905
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	TNIK SIPA1L3 TNRC6B CRTC1 PHF8 WASHC2A DDB1 NCOR1 CCDC88A SIPA1L1 POC5 EIF2A ZNF598	6.73e-05	853	146	13	28718761
Pubmed	Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer.	SIPA1L3 SAV1 FAM117B SIPA1L1 PARD3	7.31e-05	102	146	5	15778465
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	TNIK ANK3 SRC RAB11FIP1 ADCY9 EPN2 CCDC88A EFNB2 PARD3	7.69e-05	421	146	9	36976175
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	BCORL1 TNRC6B WASHC2A DDB1 UBAP2L ANKRD17 CDC27	7.73e-05	242	146	7	34011540
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	TPR SP1 DDX5 FBXO38 BPTF NCOR1 SMC3 UBAP2L	8.53e-05	332	146	8	32786267
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	KIF13B FLG USP45 HIVEP2 AMBRA1 CLASP2 FBXO38 SMC3 SIPA1L1 ANKRD17 CDC27 MTDH FOXK1 ZMYM6	9.13e-05	1005	146	14	19615732
Pubmed	Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells.	TNRC6B UBAP2L ANKRD17 LSM14A ZNF598	9.17e-05	107	146	5	30995489
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	TPR SYNM HECTD4 DDB1 BPTF EIF2A TOR1AIP1	9.47e-05	250	146	7	33536335
Pubmed	Binding of the ERα and ARNT1 AF2 domains to exon 21 of the SRC1 isoform SRC1e is essential for estrogen- and dioxin-related transcription.	SRC ARNT	1.04e-04	4	146	2	22328528
Pubmed	Nuclear receptors RXRalpha:RARalpha are repressors for human MRP3 expression.	SP1 RXRA	1.04e-04	4	146	2	17272513
Pubmed	A selective peroxisome proliferator-activated receptor-gamma modulator, telmisartan, binds to the receptor in a different fashion from thiazolidinediones.	RXRA NCOR1	1.04e-04	4	146	2	19147680
Pubmed	ADAMTS18 regulates early branching morphogenesis of lacrimal gland and has a significant association with the risk of dry eye in mice.	FN1 PARD3	1.04e-04	4	146	2	35240198
Interaction	BAG2 interactions	TNIK KIF13B PALD1 SETD1A SP1 FN1 BCORL1 AMBRA1 TEP1 NPHP4 BPTF NCOR1 ARNT PAPOLA POC5 EIF2A ZNF598 DNAJB2 FOXK1	3.97e-08	622	136	19	int:BAG2
Interaction	HDAC4 interactions	TPR KIF13B CACNA1E SP1 IFT172 BCORL1 TNRC6B GCM1 CLASP2 DDB1 RXRA DDX5 NCOR1 TENM4 UBAP2L SIPA1L1 LSM14A PARD3 MTDH	6.27e-07	744	136	19	int:HDAC4
Interaction	DYRK1B interactions	SIPA1L3 FAM117B RFX7 POM121C DDB1 SIPA1L1 FOXK1	2.76e-06	91	136	7	int:DYRK1B
Interaction	AFDN interactions	KIF13B HDAC6 FN1 SIPA1L3 SRC TNRC6B ARHGAP39 ADCY9 CCDC88A EFNB2 SIPA1L1 PARD3	2.76e-06	333	136	12	int:AFDN
Interaction	CREBBP interactions	SETD1A SP1 HIVEP2 SRC GCM1 CRTC1 CLASP2 DDB1 RXRA DDX5 FBXO38 NCOR1 ARNT PAPOLA CDC27 MTDH	2.93e-06	599	136	16	int:CREBBP
Interaction	KCNA3 interactions	TPR PALD1 HDAC6 ANK3 TNRC6B ABCC5 ARHGAP39 DDB1 ADCY9 DDX5 CCDC88A SMC3 UBAP2L SIPA1L1 LRP6 ANKRD17 PARD3 EIF2A CDC27	6.30e-06	871	136	19	int:KCNA3
Interaction	TLE3 interactions	HIVEP2 ANK3 BCORL1 GCM1 BCL9 FOXA3 DDB1 NCOR1 ARNT POM121 TBR1 TBX20	9.49e-06	376	136	12	int:TLE3
Interaction	RHOB interactions	TNIK PALD1 ANK3 SIPA1L3 SRC ABCC5 ARHGAP39 RAB11FIP1 ADCY9 PCDH17 EPN2 CCDC88A EFNB2 SIPA1L1 AGFG1 LRP6 PARD3 CDC27	1.44e-05	840	136	18	int:RHOB
Interaction	TOP3B interactions	SEMA6C PALD1 SETD1A SEMA4B HIVEP2 SIPA1L3 HECTD4 TNRC6B AMBRA1 CLASP2 BCL9 TEP1 POM121C NPHP4 WASHC2A ADCY9 NCOR1 UBAP2L PIK3CD NAV2 ANKRD17 LSM14A EIF2A ZNF598 FOXK1	1.54e-05	1470	136	25	int:TOP3B
Interaction	YWHAH interactions	KIF13B HIVEP2 FN1 SIPA1L3 SRC HECTD4 SAV1 CRTC1 FAM117B CLASP2 RAB11FIP1 RFX7 EPN2 RUSC2 CCDC88A SIPA1L1 AGFG1 NAV2 ANKRD17 PARD3 FOXK1	1.55e-05	1102	136	21	int:YWHAH
Interaction	SFN interactions	TNIK KIF13B SETD1A SIPA1L3 SAV1 FAM117B CLASP2 RAB11FIP1 DDX5 RUSC2 ARNT CCDC88A SIPA1L1 NAV2 ANKRD17 PARD3	1.79e-05	692	136	16	int:SFN
Interaction	YWHAQ interactions	TPR KIF13B HIVEP2 HDAC6 FN1 SIPA1L3 HECTD4 CRTC1 FAM117B CLASP2 RAB11FIP1 RFX7 EPN2 RUSC2 CCDC88A SIPA1L1 AGFG1 NAV2 ANKRD17 PARD3 FOXK1	1.92e-05	1118	136	21	int:YWHAQ
Interaction	PLEC interactions	SP1 HDAC6 FN1 ANK3 PHF8 BCL9 NPHP4 ADARB1 CCDC88A SMC3 MTDH FOXK1	3.57e-05	430	136	12	int:PLEC
Interaction	BCOR interactions	SP1 HDAC6 BCORL1 GCM1 DDB1 FBXO38 NCOR1 OTX2 UBAP2L TBR1	3.96e-05	302	136	10	int:BCOR
Interaction	SRF interactions	SP1 SRC BCORL1 RXRA BPTF FOXK1 ZNF292	4.44e-05	139	136	7	int:SRF
Interaction	AP2B1 interactions	TNIK AMPH HDAC6 FN1 SIPA1L3 TNRC6B EPN2 CCDC88A POM121 AGFG1 MTDH	4.66e-05	373	136	11	int:AP2B1
Interaction	YWHAB interactions	KIF13B FN1 CAMK2B SIPA1L3 SRC HECTD4 CRTC1 FAM117B CLASP2 RAB11FIP1 RFX7 EPN2 RUSC2 CCDC88A SIPA1L1 NAV2 ANKRD17 PARD3 FOXK1	5.17e-05	1014	136	19	int:YWHAB
Interaction	HDAC3 interactions	SP1 SRC GCM1 DDB1 RXRA DDX5 FBXO38 NCOR1 CCDC88A PAPOLA	5.36e-05	313	136	10	int:HDAC3
Interaction	APC interactions	TNIK TPR SAV1 CLASP2 POM121C POM121 SMC3 AGFG1 NAV2 ANKRD17 PARD3	6.79e-05	389	136	11	int:APC
Interaction	FMR1 interactions	TNIK CAMK2B TNRC6B BCL9 DDX5 NCOR1 UBAP2L ANKRD17 LSM14A PARD3 ZNF598 CDC27 MTDH	7.07e-05	536	136	13	int:FMR1
Interaction	YWHAZ interactions	KIF13B HIVEP2 HDAC6 FN1 CAMK2B SIPA1L3 HECTD4 SAV1 CRTC1 FAM117B CLASP2 RAB11FIP1 EPN2 RUSC2 NCOR1 CCDC88A SIPA1L1 NAV2 ANKRD17 PARD3 ZNF598 FOXK1	7.18e-05	1319	136	22	int:YWHAZ
Interaction	RNF214 interactions	TNRC6B EPN2 UBAP2L ANKRD17 LSM14A POC5	7.46e-05	104	136	6	int:RNF214
Interaction	NCOR2 interactions	TNIK SP1 CAMK2B GCM1 RXRA FBXO38 NCOR1 ARNT TBR1	7.80e-05	264	136	9	int:NCOR2
Interaction	RAC1 interactions	TNIK PALD1 HDAC6 FN1 ANK3 SIPA1L3 SRC ABCC5 ARHGAP39 RAB11FIP1 ADCY9 PCDH17 ARNT CCDC88A EFNB2 ARHGAP31 AGFG1 PARD3 TOR1AIP1	9.65e-05	1063	136	19	int:RAC1
Interaction	YWHAE interactions	KIF13B HIVEP2 HDAC6 FN1 SIPA1L3 SRC SAV1 CRTC1 FAM117B CLASP2 RAB11FIP1 DDB1 RUSC2 CCDC88A PAPOLA SIPA1L1 NAV2 ANKRD17 PARD3 ZNF598 FOXK1	1.03e-04	1256	136	21	int:YWHAE
Interaction	LYN interactions	TNIK HDAC6 ANK3 SRC ABCC5 ARHGAP39 PHF8 RAB11FIP1 ADCY9 ARNT CCDC88A PTPRC EFNB2 IGHA1 PARD3	1.07e-04	720	136	15	int:LYN
Interaction	FAM86B3P interactions	UBQLN1 FN1	1.35e-04	3	136	2	int:FAM86B3P
Interaction	RAB35 interactions	PALD1 HDAC6 FN1 ANK3 ABCC5 RAB11FIP1 NDRG3 ADCY9 CCDC88A EFNB2 SLC6A5 PARD3 TOR1AIP1	1.38e-04	573	136	13	int:RAB35
Interaction	RARA interactions	SP1 UBQLN1 FN1 SRC PHF8 RXRA DDX5 NCOR1	1.39e-04	223	136	8	int:RARA
Interaction	OCLN interactions	TNIK UBQLN1 ANK3 SIPA1L3 ARHGAP39 RAB11FIP1 ADCY9 CCDC88A EFNB2 SIPA1L1 AGFG1 PARD3	1.49e-04	500	136	12	int:OCLN
Interaction	RNF43 interactions	ANK3 SYNM TNRC6B POM121C DDX5 CCDC88A POM121 PARD3 DNAJB2 TOR1AIP1 MTDH	1.54e-04	427	136	11	int:RNF43
Interaction	FXR2 interactions	TNIK HDAC6 CAMK2B TNRC6B ADARB1 POM121 UBAP2L ANKRD17 LSM14A ZNF598 MTDH	1.64e-04	430	136	11	int:FXR2
Interaction	RHOF interactions	PALD1 HDAC6 ANK3 SIPA1L3 ABCC5 ARHGAP39 POM121C ADCY9 PCDH17 CCDC88A EFNB2 AGFG1 PARD3 TOR1AIP1	1.87e-04	673	136	14	int:RHOF
Interaction	LATS1 interactions	WWC3 SIPA1L3 SRC SAV1 TNRC6B NPHP4 DDB1 CCDC88A SIPA1L1 TBR1 PARD3	2.00e-04	440	136	11	int:LATS1
Interaction	TRIM21 interactions	TPR FLG CACNA1E SETD1A IGKV1-8 HDAC6 FN1 RAB11FIP1 DDX5 IGLV3-9 BPTF ZNF598 CDC27 MTDH	2.38e-04	689	136	14	int:TRIM21
Interaction	SMG5 interactions	ANK3 TNRC6B UBAP2L ANKRD17 LSM14A	2.62e-04	84	136	5	int:SMG5
Interaction	PGR interactions	SP1 SRC BPTF NCOR1 HERC4	2.62e-04	84	136	5	int:PGR
Interaction	CLTB interactions	AMPH HDAC6 FN1 TNRC6B EPN2 SMC3 AGFG1	2.64e-04	185	136	7	int:CLTB
Interaction	YWHAG interactions	KIF13B HIVEP2 FN1 SIPA1L3 SRC HECTD4 CRTC1 FAM117B CLASP2 RAB11FIP1 RFX7 EPN2 RUSC2 CCDC88A SIPA1L1 AGFG1 NAV2 ANKRD17 PARD3 FOXK1	2.69e-04	1248	136	20	int:YWHAG
Interaction	MYB interactions	SETD1A PHF8 DDB1 NCOR1 SMC3 ZNF292	2.88e-04	133	136	6	int:MYB
Interaction	NR1I2 interactions	SRC DDB1 RXRA NCOR1	3.07e-04	48	136	4	int:NR1I2
Interaction	CEP43 interactions	TNIK SYNM SAV1 RAB11FIP1 DDB1 NCOR1 ANKRD17	3.11e-04	190	136	7	int:CEP43
Interaction	GSK3A interactions	TNIK HDAC6 SIPA1L3 TNRC6B CLASP2 RFX7 WASHC2A DDX5 CCDC88A SIPA1L1 LRP6	3.15e-04	464	136	11	int:GSK3A
Interaction	MAD2L1 interactions	TPR SETD1A PHF8 BPTF ARNT CCDC88A CDC27 TOR1AIP1	3.18e-04	252	136	8	int:MAD2L1
Interaction	NUP43 interactions	SETD1A CAMK2B MUC19 TNRC6B PHF8 POM121C DDB1 BPTF NCOR1 CCDC88A POM121 EIF2A ZNF292	3.20e-04	625	136	13	int:NUP43
Interaction	NAA40 interactions	TNIK TPR PALD1 TNRC6B POM121C DDB1 DDX5 PAPOLA UBAP2L AGFG1 ANKRD17 LSM14A EIF2A ZNF598 HERC4 TOR1AIP1 MTDH	3.20e-04	978	136	17	int:NAA40
Cytoband	22q11.2	IGLV8-61 IGLV3-27 IGLV3-25 IGLV3-22 IGLV3-21 IGLV3-9 IGLV3-1	1.25e-07	120	146	7	22q11.2
Cytoband	Ensembl 112 genes in cytogenetic band chr22q11	IGLV8-61 IGLV3-27 IGLV3-25 IGLV3-22 IGLV3-21 IGLV3-9 IGLV3-1	4.10e-04	419	146	7	chr22q11
GeneFamily	CD molecules\|Mucins	MUC19 MUC16 MUC12 MUC3A MUC5AC	9.33e-08	21	101	5	648
GeneFamily	Immunoglobulin lambda locus at 22q11.2	IGLV8-61 IGLV3-27 IGLV3-25 IGLV3-22 IGLV3-21 IGLV3-9 IGLV3-1	6.52e-07	89	101	7	353
GeneFamily	Fibronectin type III domain containing	FN1 ABI3BP DSCAML1 SNED1 PTPRC IGSF9	2.77e-04	160	101	6	555
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	ANK3 SIPA1L3 AMBRA1 RFX7 ADCY9 SIPA1L1 NAV2 PARD3 HERC4	1.61e-08	196	144	9	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	ANK3 SIPA1L3 TNRC6B AMBRA1 CLASP2 RFX7 PARD3 HERC4	2.86e-07	199	144	8	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-5\|TCGA-Stomach / Sample_Type by Project: Shred V9	CACNA1E CCDC166 ACRV1 BCORL1 NPHP4 LGSN	2.75e-06	121	144	6	392700c5032b83d4d4e191fea9bcd170e4567b9d
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	ANK3 SIPA1L3 AMBRA1 ADCY9 SIPA1L1 NAV2 PARD3	3.80e-06	198	144	7	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	TPR TNRC6B BPTF SMC3 ANKIB1 CDC27 ZNF292	3.92e-06	199	144	7	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	TPR TNRC6B KMT2E BPTF NCOR1 SMC3 ZNF292	3.92e-06	199	144	7	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	metastatic_Lymph_Node-B_lymphocytes-Plasma_cells\|metastatic_Lymph_Node / Location, Cell class and cell subclass	IGLV8-61 IGLV3-27 IGLV3-25 IGLV3-9 IGLV3-1 IGHA1	6.93e-06	142	144	6	5ba3a33c2ee20be8baaed97536ca6e9d1de6752f
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PALD1 SIGLEC8 MUC16 FAM117B SLC10A7 FBXO41	9.12e-06	149	144	6	a85a051e0d82430160967e72fa04b55f43e84513
ToppCell	BAL-Mild-Myeloid-cDC-cDC-cDC_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PALD1 SIGLEC8 MUC16 FAM117B SLC10A7 FBXO41	9.48e-06	150	144	6	7a381f5ae94eba5eb60dcbf83416b4eb18c279ea
ToppCell	tumor_Lymph_Node_/_Brain-B_lymphocytes-MALT_B_cells\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	IGKV1-8 IGLV3-27 IGLV3-25 IGLV3-21 IGLV3-1 IGHA1	1.32e-05	159	144	6	204e5a675f4684c9570c24c8d34bbf632fd8164a
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	SP1 IFT172 HECTD4 KMT2E USF3 UBAP2L	1.69e-05	166	144	6	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	Mild/Remission-B_naive-4\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	PELI1 ADARB1 DDX5 USF3 PTPRC SIPA1L1	1.87e-05	169	144	6	c3a6179a64589a370108fea809b157839347759c
ToppCell	BAL-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-8 IGLV8-61 IGLV3-25 IGLV3-21 IGLV3-1 IGHA1	1.87e-05	169	144	6	307571e57c3bfdf15f0fe1a8b36585e8e4f8a207
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-8 IGLV3-27 IGLV3-25 IGLV3-21 IGLV3-9 IGHA1	2.66e-05	180	144	6	cea079bc02e08c46600eed05ab9924ec90e1e3d3
ToppCell	normal_Lymph_Node-B_lymphocytes-Plasma_cells\|normal_Lymph_Node / Location, Cell class and cell subclass	IGKV1-8 IGLV8-61 IGLV3-25 IGLV3-21 IGLV3-1 IGHA1	2.75e-05	181	144	6	949ac3b60e7fb5968da4c4e872965fb4e10f4a35
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-8 IGLV8-61 IGLV3-27 IGLV3-25 IGLV3-21 IGHA1	2.75e-05	181	144	6	e47664a264a2c37390d1668ce04eef2e0172f4cb
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SH3TC2 ABI3BP DSCAML1 IGSF9 PARD3 HYDIN	2.83e-05	182	144	6	5e1b316599436740f1b30875f0ebd33c3edfb2b6
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	AOX1 MUC19 GCM1 LGSN ANKIB1 KIAA1755	2.92e-05	183	144	6	d73cac83cde82665f110baad7cf28db75f9ffe52
ToppCell	cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IGKV1-8 IGLV3-25 IGLV3-21 IGLV3-9 IGLV3-1 IGHA1	2.92e-05	183	144	6	5ab4aa0304b832f98fff89b6c24ad5b7dd014c11
ToppCell	Mild_COVID-19-B_cell\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	IGKV1-8 IGLV8-61 IGLV3-25 IGLV3-21 IGLV3-1 IGHA1	2.92e-05	183	144	6	dea119e2988e954475f557f0bbe12556a83e81a4
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-8 IGLV8-61 IGLV3-25 IGLV3-21 IGLV3-9 IGHA1	2.92e-05	183	144	6	cf5c98f451a568308c52da5c926543dd4836c6b2
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-8 IGLV3-27 IGLV3-25 IGLV3-21 IGLV3-9 IGHA1	3.01e-05	184	144	6	15f2c10101ccc8ed059520fc082ee42593dff269
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-8 IGLV3-27 IGLV3-25 IGLV3-21 IGLV3-9 IGHA1	3.01e-05	184	144	6	a90a58d9e319afa1cd572e4c2f516fadc42f56e5
ToppCell	Brain_organoid-organoid_Kanton_Nature\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	ANK3 KMT2E BPTF NCOR1 EFNB2 SMC3	3.10e-05	185	144	6	857c7ca8493e91ef1d0078ddafd6082020f9b169
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IGKV1-8 IGLV3-27 IGLV3-25 IGLV3-21 IGLV3-9 IGHA1	3.10e-05	185	144	6	0fff2608f507e019ebb69c27e58fd5be3b049bef
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FN1 ABI3BP SNED1 TENM4 KIAA1755 TBX20	3.10e-05	185	144	6	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IGKV1-8 IGLV3-27 IGLV3-25 IGLV3-21 IGLV3-9 IGHA1	3.10e-05	185	144	6	79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9
ToppCell	COVID-19-Fibroblasts-Adventitial_FB\|COVID-19 / group, cell type (main and fine annotations)	ABI3BP AOX1 SNED1 NAV2 KIAA1755 PARD3	3.10e-05	185	144	6	a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MUC19 MUC16 RXRA CCDC88A TENM4 AGFG1	3.20e-05	186	144	6	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	ILEUM-inflamed-(8)_Fibroblast-(8)_Smooth_muscle_cells\|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ABI3BP SYNM PCDH17 EFNB2 IGHA1 HYDIN	3.20e-05	186	144	6	cacc2f0b2ed46516173b61ba1c5c226a2db7cddc
ToppCell	COVID-19-Heart-Fib_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	AMPH ABI3BP SNED1 TENM4 KIAA1755 TBX20	3.40e-05	188	144	6	fe361215f4ba841aa5e1e581fb56f2f4d3ccd201
ToppCell	COPD-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	SIPA1L3 PELI1 RAB11FIP1 SNED1 IGHA1 SIPA1L1	3.60e-05	190	144	6	1e85ee686ff6dd27c69415d524d54fa825b1daad
ToppCell	5'-Adult-LargeIntestine-Hematopoietic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGKV1-8 IGLV3-25 IGLV3-21 PTPRC IGHA1 CD96	3.71e-05	191	144	6	d1d30279ed4612b4f62c225d9eabf0b8a7a09d11
ToppCell	ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	FN1 ABI3BP SYNM RAB11FIP1 CCDC88A IGHA1	3.82e-05	192	144	6	d43caf42ec744e895137f31ef65a990e250669d2
ToppCell	LA-02._Fibroblast_II\|LA / Chamber and Cluster_Paper	FN1 ABI3BP AOX1 SNED1 NAV2 TBX20	4.05e-05	194	144	6	234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCell	COVID_non-vent-Lymphocytic-T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	TNIK HIVEP2 ANK3 TNRC6B KMT2E CD96	4.16e-05	195	144	6	4bdedd924564a260841a9153604026b57487c83d
ToppCell	COVID-19-Heart-Fib_1\|Heart / Disease (COVID-19 only), tissue and cell type	AMPH FN1 ABI3BP SNED1 TENM4 KIAA1755	4.16e-05	195	144	6	f423baa36ac7cdc383c033e35a7d17e6bf913323
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	FN1 ABI3BP ADARB1 SNED1 NAV2 PARD3	4.16e-05	195	144	6	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	mLN-B_cell-B_cell_IgG_Plasma\|mLN / Region, Cell class and subclass	ARHGAP39 FOXA3 IGLV8-61 IGLV3-1 TACR2 PARD3	4.28e-05	196	144	6	03b79f237e4f7ebab46b277d05377569c6342cf7
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 FN1 ADARB1 SNED1 EFNB2 ARHGAP31	4.28e-05	196	144	6	8ad8efb631164b46f0c082572270188e5ead20bf
ToppCell	mLN-(2)_B_cell-(21)_B_cell_IgG_Plasma\|mLN / shred on region, Cell_type, and subtype	ARHGAP39 FOXA3 IGLV8-61 IGLV3-1 TACR2 PARD3	4.28e-05	196	144	6	e8b12b046d42a58e6f4d9419ab05a5c55e764f34
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 FN1 ADARB1 SNED1 EFNB2 ARHGAP31	4.28e-05	196	144	6	9606ea7e42f707e69ea891b3521037613b9675f5
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	PALD1 FN1 PCDH17 SNED1 EFNB2 ARHGAP31	4.28e-05	196	144	6	b71b197cb92117dd9efaa13de000841901cc4ca8
ToppCell	Biopsy_IPF-Immune-Plasma_cells\|Biopsy_IPF / Sample group, Lineage and Cell type	IGKV1-8 IGLV3-25 IGLV3-21 IGLV3-9 IGLV3-1 IGHA1	4.28e-05	196	144	6	a1b6a8000b86efcb07843998aa3a49bb1f54bcda
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-8 IGLV8-61 IGLV3-27 IGLV3-9 IGLV3-1 IGHA1	4.28e-05	196	144	6	b3d5540fe8ab9a9cbb9ab5350f5cb0e1aae93584
ToppCell	PCW_10-12\|World / Celltypes from embryonic and fetal-stage human lung	TNIK HIVEP2 FN1 ABI3BP KMT2E SNED1	4.41e-05	197	144	6	47fd8b0d596c5db1a722473c8efbb17a6bbe7538
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-8 IGLV3-27 IGLV3-25 IGLV3-21 IGLV3-1 IGHA1	4.41e-05	197	144	6	9fe1b757f76c2d43d39aa9ac500eaba98723985c
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	FN1 ABI3BP AOX1 ADARB1 SNED1 NAV2	4.53e-05	198	144	6	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	(04)_Interm._basal>secr.-(2)_GFP_FOXI1\|(04)_Interm._basal>secr. / shred by cell type by condition	KMT2E BPTF SMC3 ANKIB1 CDC27 ZNF292	4.66e-05	199	144	6	53ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell	(05)_Secretory-(2)_GFP_FOXI1\|(05)_Secretory / shred by cell type by condition	BPTF SMC3 ANKIB1 CDC27 MTDH ZNF292	4.66e-05	199	144	6	d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_\|World / Primary Cells by Cluster	TNIK HIVEP2 ANK3 CAMK2B CSRNP3 TBR1	4.66e-05	199	144	6	058373b4ac3cec2108cb24265628ff0a50646e33
ToppCell	(01)_IL1RL1+-(2)_GFP_FOXI1\|(01)_IL1RL1+ / shred by cell type by condition	TPR BPTF CCDC88A SMC3 CDC27 ZNF292	4.66e-05	199	144	6	a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FN1 ABI3BP ADARB1 SNED1 NAV2 KIAA1755	4.79e-05	200	144	6	a4ec0e80f5422b91b85264a9bb74568dd577e285
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate\|5w / Sample Type, Dataset, Time_group, and Cell type.	SETD1A ANK3 CAMK2B HECTD4 TNRC6B EFNB2	4.79e-05	200	144	6	c92e4fc0442404481fcac623d691dae6215b852d
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TPR KMT2E DDX5 BPTF PTPRC ZNF292	4.79e-05	200	144	6	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	(08)_Brush+PNEC-(2)_GFP_FOXI1\|(08)_Brush+PNEC / shred by cell type by condition	ZNF618 KMT2E BPTF ANKRD17 ZNF292	8.63e-05	138	144	5	817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCell	ASK440-Epithelial-Secretory\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	FN1 ABI3BP CCDC88A PTPRC IGHA1	9.87e-05	142	144	5	ea694a907eaa46c55665692cb830870281700e40
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4\|368C / Donor, Lineage, Cell class and subclass (all cells)	AMBRA1 ARHGAP39 IGLV8-61 IGLV3-1 PTPRC	1.28e-04	150	144	5	c843bcf98c5fad2ca4339602f721f3fb782ae353
ToppCell	TCGA-Lung\|World / Sample_Type by Project: Shred V9	LGSN IGLV3-27 IGLV3-25 IGLV3-21 IGLV3-9	1.28e-04	150	144	5	8c133206786e8f22bb70f2a7de9c0cb7f9ea9313
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-astrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEMA4B TMC2 ZNF618 AOX1 MUC5AC	1.44e-04	154	144	5	5ed64bbf603290e6dc34f81d145982690b89dd0d
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANK3 KLHDC7B MUC16 CFAP20DC MUC5AC	1.58e-04	157	144	5	c43f2e1ea53b375a7432f17f87cfef3b2261003d
ToppCell	E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PALD1 CCDC88A PTPRC MED12L FCRLB	1.63e-04	158	144	5	f61ebe3a316e4259387cd9da83707f15e6473cae
ToppCell	normal_Lung-B_lymphocytes-MALT_B_cells\|normal_Lung / Location, Cell class and cell subclass	IGKV1-8 IGLV8-61 IGLV3-25 IGLV3-1 IGHA1	1.68e-04	159	144	5	fbd0131b66f4267f7b0d6c3ad874ad097b859074
ToppCell	P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	AMPH FN1 ADARB1 NAV2 MUC5AC	1.78e-04	161	144	5	b19f82dd98a3064581793711bb70373f18abecd9
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	PALD1 SYNM SIGLEC8 MED12L LSM14A	1.83e-04	162	144	5	810881210e015c788814e4fe8d7a24c929cf2621
ToppCell	droplet-Marrow-BM-30m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1E SH3TC2 FN1 RXRA DNAJB2	1.83e-04	162	144	5	75df7ff779a3b9159ba97d852da1f8df650b9ce5
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-8 IGLV3-27 PNMA5 IGHA1 HERC4	1.83e-04	162	144	5	b46158e260bd2f35702cec73e3b035e8e9ec4469
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	SAV1 CLASP2 RAB11FIP1 IGHA1 SIPA1L1	1.88e-04	163	144	5	6bed27d2f67a430a847da5eb47878d14b4949c45
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	RAB11FIP1 CCDC88A PTPRC ARHGAP31 FCRLB	2.05e-04	166	144	5	63dc58864268b4e7779e4c45155022556fc634f9
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	HIVEP2 ANK3 FAM117B SMC3 ANKRD17	2.11e-04	167	144	5	ced6ed9b412739c6ced622523347c10295edbf53
ToppCell	Control\|World / group, cell type (main and fine annotations)	ANK3 RAB11FIP1 NAV2 PARD3 MUC5AC	2.16e-04	168	144	5	a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell	tumor_Lung-B_lymphocytes-Plasma_cells\|tumor_Lung / Location, Cell class and cell subclass	IGKV1-8 IGLV8-61 IGLV3-21 IGLV3-1 IGHA1	2.23e-04	169	144	5	b36b7632ce55fc7b6b8b66020563d360b3de6fd7
ToppCell	metastatic_Brain-B_lymphocytes-Plasma_cells\|metastatic_Brain / Location, Cell class and cell subclass	IGLV3-27 IGLV3-25 IGLV3-9 IGLV3-1 IGHA1	2.29e-04	170	144	5	53634da9e9c72f6400639954c286c6e38ea5a188
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SEMA6C KIF13B ARHGAP39 PHF8 HYDIN	2.35e-04	171	144	5	1854a777d9eb9d3fc3ed3632332a6f89ce8131da
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-8 IGLV8-61 IGLV3-25 IGLV3-21 IGHA1	2.48e-04	173	144	5	0ca2169a275404118038c0489a48062879488765
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	SAV1 CLASP2 RAB11FIP1 IGHA1 SIPA1L1	2.48e-04	173	144	5	d56e337eae727a29cd53cfd628e1b3c0a98e1f51
ToppCell	facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIVEP2 CAMK2B DSCAML1 PTPRC NAV2	2.61e-04	175	144	5	f24b664b9056b5976bf2222e8013f15c09e049ad
ToppCell	metastatic_Brain-B_lymphocytes-MALT_B_cells\|metastatic_Brain / Location, Cell class and cell subclass	IGKV1-8 IGLV8-61 IGLV3-21 IGLV3-1 IGHA1	2.68e-04	176	144	5	50e207403d48ce1b55a78897adb5519a2430a626
ToppCell	Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Drd1_(Deep_layer_pyramidal_cells)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	PGS1 IFT172 PHF8 POC5 EIF2A	2.68e-04	176	144	5	3c76a5c4ca2b378667cb155fbb9675519572b35d
ToppCell	IPF-Lymphoid-B_Plasma\|IPF / Disease state, Lineage and Cell class	IGKV1-8 IGLV3-27 IGLV3-21 IGLV3-1 IGHA1	2.68e-04	176	144	5	e4f33f6cd140dd4fa3002bcd65ac8005d27865d1
ToppCell	-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	IGKV1-8 IGLV3-25 IGLV3-21 IGLV3-1 IGHA1	2.75e-04	177	144	5	ae2d2e138946535596fa30a55207f261cafda461
ToppCell	mild_COVID-19_(asymptomatic)-B_memory\|World / disease group, cell group and cell class (v2)	ANK3 MUC19 SAV1 SNED1 IGHA1	2.75e-04	177	144	5	057871e211c6508b2a679d391f3cf0ac7ccfc628
ToppCell	tumor_Lung-B_lymphocytes-MALT_B_cells\|tumor_Lung / Location, Cell class and cell subclass	IGKV1-8 IGLV3-21 IGLV3-9 IGLV3-1 IGHA1	2.75e-04	177	144	5	37e03f51925345f5f716ef3abe1d2c4ccf129020
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7\|TCGA-Colorectal / Sample_Type by Project: Shred V9	HIVEP2 FN1 BCORL1 NDRG3 LSM14A	2.83e-04	178	144	5	edc76b8f15056ec1c9a1c61a048b6331a92592d6
ToppCell	B_cells-Naive_B_cells_\|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis	WWC3 HECTD4 FAM117B ADARB1 PTPRC	2.83e-04	178	144	5	71ac2eca5cf13a91f86b80690748b0788392dcfc
ToppCell	BAL-Mild-cDC_4\|Mild / Compartment, Disease Groups and Clusters	SIGLEC8 MUC16 FAM117B SLC10A7 FBXO41	2.90e-04	179	144	5	68511e87b12b8253de7771e5ccfc5869248b8450
ToppCell	LA-01._Fibroblast_I\|LA / Chamber and Cluster_Paper	ABI3BP AOX1 SNED1 KIAA1755 TBX20	2.90e-04	179	144	5	dcb6ec9ae72b13fe388b72dace2815293fafe8ee
ToppCell	RA-01._Fibroblast_I\|World / Chamber and Cluster_Paper	FN1 ABI3BP AOX1 NAV2 TBX20	3.05e-04	181	144	5	2b6ddeb53a79a658e2ba78527ff48c155b20daa6
ToppCell	BAL-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGKV1-8 IGLV8-61 IGLV3-25 IGLV3-1 IGHA1	3.05e-04	181	144	5	700adfb41e4e377530f0dd31be89e12f109f3469
ToppCell	droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNIK SH3TC2 ADARB1 PCDH17 EFNB2	3.05e-04	181	144	5	a53f05c4c47465ee62e353716456bd09ab464b23
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TPR FN1 TEP1 CCDC88A PTPRC	3.13e-04	182	144	5	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	metastatic_Lymph_Node-B_lymphocytes-Plasma_cells\|B_lymphocytes / Location, Cell class and cell subclass	IGLV8-61 IGLV3-27 IGLV3-25 IGLV3-1 IGHA1	3.13e-04	182	144	5	27d1688fdfc570cedd233aa7030bce7d9b604d42
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FN1 ABI3BP TENM4 KIAA1755 TBX20	3.13e-04	182	144	5	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNIK SH3TC2 ADARB1 PCDH17 EFNB2	3.21e-04	183	144	5	709a486154b3157427deb3b8886b63ac39ea42dd
ToppCell	droplet-Liver-nan-3m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNIK SH3TC2 ADARB1 PCDH17 EFNB2	3.21e-04	183	144	5	dc06f19f6f80f4c7f13f1f990c1fe0f91ba64ea7
ToppCell	3'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-Treg\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	KLHDC7B RAB11FIP1 PNMA5 PTPRC CD96	3.21e-04	183	144	5	450c30d2e389fcb17825394c27f9ccc4f33022e3
ToppCell	Control-APC-like-Dendritic_cells\|Control / group, cell type (main and fine annotations)	PALD1 CCDC88A TENM4 PTPRC MED12L	3.21e-04	183	144	5	8f9c8e2436f18ea7c265b08e4e149e19cb513a16
ToppCell	Control-APC-like\|Control / group, cell type (main and fine annotations)	PALD1 CCDC88A TENM4 PTPRC MED12L	3.21e-04	183	144	5	c313ac72cc9fa1583456d452393f61f0a4ca33a8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PALD1 PCDH17 SNED1 EFNB2 ARHGAP31	3.29e-04	184	144	5	688428103e8b19f45f2f65d70a0f30c904c8411c
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-T_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNIK PELI1 ARHGAP31 NAV2 CD96	3.29e-04	184	144	5	8c23945bafe8926f25836bc208115edd5214a2b0
Drug	Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A	TPR SRC RFX7 TEP1 FBXO38 SMC3 CUZD1 LRP6 CDC27 ZMYM6	2.44e-07	192	136	10	4104_DN
Drug	irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A	HIVEP2 EPN2 BPTF TENM4 SIPA1L1 NAV2 ANKRD17 LSM14A PARD3	9.11e-07	171	136	9	7535_DN
Drug	Azathymine, 6 [932-53-6]; Down 200; 31.4uM; MCF7; HT_HG-U133A	SP1 ABI3BP SRC TEP1 NDRG3 ADARB1 EPN2 SIPA1L1 CUZD1	2.71e-06	195	136	9	4106_DN
Drug	Ethamsylate [2624-44-4]; Up 200; 15.2uM; MCF7; HT_HG-U133A	HIVEP2 SIGLEC8 BCORL1 PHF8 TEP1 RUSC2 ARNT FBXO41 LRP6	2.82e-06	196	136	9	7335_UP
Drug	Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A	KIF13B SP1 HIVEP2 ANK3 BCORL1 AMBRA1 EFNB2 PAPOLA ZMYM6	2.82e-06	196	136	9	1684_DN
Drug	phenformin hydrochloride; Up 200; 10uM; MCF7; HG-U133A	CAMK2B AMBRA1 CLASP2 NDRG3 ADARB1 ARNT PIK3CD PARD3 DNAJB2	2.94e-06	197	136	9	21_UP
Drug	Milrinone [78415-72-2]; Down 200; 19uM; MCF7; HT_HG-U133A	FN1 ANK3 GATB BCL9 RXRA ADCY9 UBAP2L FBXO41 LRP6	3.07e-06	198	136	9	7210_DN
Drug	Betulin [473-98-3]; Down 200; 9uM; MCF7; HT_HG-U133A	SP1 FN1 SYNM SRC SAV1 AMBRA1 ADCY9 FBXO38 ZMYM6	3.20e-06	199	136	9	7454_DN
Drug	Amiprilose hydrochloride [60414-06-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A	SRC TNRC6B ADARB1 RUSC2 FBXO38 PIK3CD SIPA1L1 FBXO41 PARD3	3.20e-06	199	136	9	4119_DN
Drug	Benzamide	DRD3 ACRV1 ADCY9 SMC3 SLC6A5 TACR2	1.29e-05	86	136	6	CID000002331
Drug	Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A	TPR CCDC88A EFNB2 PAPOLA SMC3 AGFG1 CDC27 HERC4	1.85e-05	189	136	8	4271_DN
Drug	Rilmenidine hemifumarate [54187-04-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A	AMPH SIGLEC8 CAMK2B SIPA1L3 SRC RUSC2 MUC5AC TOR1AIP1	2.07e-05	192	136	8	6512_UP
Drug	N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; PC3; HT_HG-U133A	TPR CCDC88A EFNB2 CSRNP3 SMC3 AGFG1 PARD3 HERC4	2.07e-05	192	136	8	4311_DN
Drug	Glycocholic acid [475-31-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A	KIF13B FN1 ANK3 SAV1 PELI1 NCOR1 SIPA1L1 DNAJB2	2.23e-05	194	136	8	5316_DN
Drug	Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A	TNIK FBXO38 CCDC88A EFNB2 PAPOLA CUZD1 HERC4 TOR1AIP1	2.32e-05	195	136	8	3710_DN
Drug	Aspartic acid, N-acetyl (R,S) [997-55-7]; Down 200; 22.8uM; MCF7; HT_HG-U133A	CAMK2B BCL9 TEP1 ADARB1 RUSC2 CUZD1 FBXO41 PARD3	2.40e-05	196	136	8	4125_DN
Drug	(-)-depudecin; Down 200; 1uM; MCF7; HT_HG-U133A_EA	SIPA1L3 HECTD4 TNRC6B AMBRA1 ADARB1 EPN2 UBAP2L DNAJB2	2.40e-05	196	136	8	982_DN
Drug	Etofenamate [30544-47-9]; Down 200; 10.8uM; MCF7; HT_HG-U133A	TPR SETD1A RUSC2 FBXO38 ARNT PIK3CD CUZD1 CDC27	2.40e-05	196	136	8	4108_DN
Drug	Glibenclamide [10238-21-8]; Down 200; 8uM; MCF7; HT_HG-U133A	FN1 SIPA1L3 SAV1 TNRC6B CLASP2 BCL9 ARNT FBXO41	2.49e-05	197	136	8	7202_DN
Drug	genistein; Up 200; 10uM; MCF7; HT_HG-U133A	HIVEP2 FN1 SYNM SIPA1L3 CRTC1 TECTA CUZD1 NAV2	2.49e-05	197	136	8	6952_UP
Drug	Oxyphenbutazone [129-20-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A	KIF13B AOX1 TNRC6B CRTC1 PHF8 ADARB1 RUSC2 CUZD1	2.49e-05	197	136	8	3582_DN
Drug	Penbutolol sulfate [38363-32-5]; Down 200; 5.8uM; MCF7; HT_HG-U133A	SIPA1L3 SRC SAV1 NPHP4 NCOR1 PAPOLA UBAP2L LRP6	2.49e-05	197	136	8	7476_DN
Drug	Carbinoxamine maleate salt [3505-38-2]; Down 200; 9.8uM; PC3; HT_HG-U133A	HDAC6 HECTD4 EPN2 FBXO38 UBAP2L PIK3CD LRP6 TOR1AIP1	2.49e-05	197	136	8	7138_DN
Drug	Glutethimide, para-amino [125-84-8]; Down 200; 17.2uM; MCF7; HT_HG-U133A	SETD1A SRC BCL9 NPHP4 ADARB1 FBXO38 ARNT LRP6	2.49e-05	197	136	8	7463_DN
Drug	Convolamine hydrochloride [500-56-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	FN1 SIPA1L3 BCORL1 AOX1 AMBRA1 FBXO38 NCOR1 ZMYM6	2.49e-05	197	136	8	7230_DN
Drug	Droperidol [548-73-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A	HDAC6 GATB AMBRA1 BCL9 EPN2 ARNT SIPA1L1 ZMYM6	2.58e-05	198	136	8	5690_DN
Drug	Isometheptene mucate; Down 200; 8.2uM; MCF7; HT_HG-U133A	SYNM BCORL1 GATB SAV1 CRTC1 CLASP2 ARNT DNAJB2	2.58e-05	198	136	8	6524_DN
Drug	Sulfisoxazole [127-69-5]; Up 200; 15uM; MCF7; HT_HG-U133A	FN1 ABI3BP SIGLEC8 CRTC1 PHF8 PIK3CD CUZD1 CD96	2.58e-05	198	136	8	5257_UP
Drug	Napelline [5008-52-6]; Up 200; 11.2uM; PC3; HT_HG-U133A	TNIK SP1 CAMK2B TEP1 ADARB1 PTPRC PIK3CD CUZD1	2.58e-05	198	136	8	4486_UP
Drug	ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA	TPR BPTF EFNB2 SMC3 CDC27 MTDH ZNF292	9.58e-05	177	136	7	985_DN
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	TPR BPTF CCDC88A EFNB2 SMC3 AGFG1 CDC27	9.92e-05	178	136	7	3998_DN
Drug	Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A	TPR ANK3 BPTF EFNB2 SMC3 AGFG1 CDC27	1.03e-04	179	136	7	4585_DN
Drug	gamma-tBMTX	AOX1 MUC5AC	1.06e-04	3	136	2	CID000100824
Drug	Gr100679	DRD3 TACR2	1.06e-04	3	136	2	CID005311129
Drug	SAHA; Up 200; 10uM; MCF7; HT_HG-U133A	KIF13B FN1 BCORL1 PELI1 RAB11FIP1 PIK3CD NAV2	1.06e-04	180	136	7	6939_UP
Drug	PK 11195	SRC RXRA NCOR1	1.33e-04	17	136	3	ctd:C037850
Drug	Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A	TPR ANK3 RFX7 TEP1 CCDC88A EFNB2 AGFG1	1.35e-04	187	136	7	4323_DN
Drug	Dipyrone [5907-38-0]; Down 200; 12uM; PC3; HT_HG-U133A	TPR TEP1 CCDC88A EFNB2 PAPOLA SMC3 AGFG1	1.39e-04	188	136	7	4310_DN
Drug	Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A	TNIK TPR ABI3BP EFNB2 SMC3 AGFG1 HERC4	1.49e-04	190	136	7	4306_DN
Drug	Syrosingopine [84-36-6]; Down 200; 6uM; MCF7; HT_HG-U133A	WWC3 GATB AMBRA1 ADCY9 EFNB2 UBAP2L FBXO41	1.49e-04	190	136	7	6213_DN
Drug	Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A	TPR TEP1 CCDC88A SMC3 AGFG1 HERC4 TOR1AIP1	1.54e-04	191	136	7	4303_DN
Drug	Ceforanide [60925-61-3]; Down 200; 7.6uM; MCF7; HT_HG-U133A	HDAC6 FN1 TNRC6B ABCC5 TEP1 NCOR1 LRP6	1.54e-04	191	136	7	5351_DN
Drug	Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A	TNIK TPR RFX7 EFNB2 AGFG1 CDC27 HERC4	1.54e-04	191	136	7	4269_DN
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	TPR AOX1 ADCY9 EPN2 ARNT SIPA1L1 LSM14A	1.54e-04	191	136	7	1057_DN
Drug	prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A	SRC ADARB1 RXRA ARNT SIPA1L1 LRP6 MUC5AC	1.54e-04	191	136	7	6586_UP
Drug	Vincamine [1617-90-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A	HIVEP2 CAMK2B SRC AOX1 CRTC1 PCDH17 SIPA1L1	1.54e-04	191	136	7	3976_DN
Drug	Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; PC3; HT_HG-U133A	TNIK TPR RFX7 EFNB2 AGFG1 CDC27 HERC4	1.59e-04	192	136	7	4268_DN
Drug	ICI 182,780; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA	HDAC6 BCORL1 TNRC6B AMBRA1 RFX7 EFNB2 DNAJB2	1.59e-04	192	136	7	1076_UP
Drug	Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; PC3; HT_HG-U133A	TNIK TPR ANK3 BCORL1 BCL9 NCOR1 ZNF292	1.59e-04	192	136	7	7280_DN
Drug	Benfotiamine [22457-89-2]; Down 200; 8.6uM; HL60; HT_HG-U133A	SETD1A NDRG3 ADARB1 ARNT FBXO41 LRP6 PARD3	1.64e-04	193	136	7	2177_DN
Drug	Tropicamide [1508-75-4]; Down 200; 14uM; PC3; HT_HG-U133A	TPR SETD1A FN1 RFX7 CCDC88A LRP6 HERC4	1.64e-04	193	136	7	4280_DN
Drug	Clobetasol propionate [25122-46-7]; Down 200; 8.6uM; MCF7; HT_HG-U133A	TPR SP1 TEP1 FBXO38 LSM14A HERC4 TOR1AIP1	1.64e-04	193	136	7	6835_DN
Drug	Progesterone [57-83-0]; Down 200; 12.8uM; PC3; HT_HG-U133A	TNIK SH3TC2 ACRV1 AMBRA1 EPN2 RUSC2 ARNT	1.64e-04	193	136	7	6646_DN
Drug	Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; PC3; HT_HG-U133A	TNIK TPR RFX7 CCDC88A EFNB2 SMC3 AGFG1	1.69e-04	194	136	7	4308_DN
Drug	Fusaric acid [536-69-6]; Down 200; 22.4uM; MCF7; HT_HG-U133A	ANK3 ABI3BP SRC SAV1 EPN2 SIPA1L1 ZMYM6	1.69e-04	194	136	7	4105_DN
Drug	ICI 182,780; Up 200; 0.01uM; MCF7; HT_HG-U133A	SETD1A FN1 ACRV1 SRC CRTC1 RUSC2 ARNT	1.69e-04	194	136	7	6955_UP
Drug	Acemetacin [53164-05-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A	KIF13B SP1 SRC EPN2 ARNT LRP6 DNAJB2	1.69e-04	194	136	7	7442_UP
Drug	Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A	TPR ABI3BP CCDC88A EFNB2 SMC3 AGFG1 HERC4	1.69e-04	194	136	7	4312_DN
Drug	Piribedil hydrochloride [78213-63-5]; Down 200; 12uM; MCF7; HT_HG-U133A	SP1 ABI3BP EPN2 RUSC2 NCOR1 HERC4 ZMYM6	1.75e-04	195	136	7	3512_DN
Drug	Flurandrenolide [1524-88-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A	AMPH FN1 ABI3BP SIPA1L3 ADARB1 PCDH17 FBXO41	1.75e-04	195	136	7	6039_UP
Drug	Tiletamine hydrochloride; Down 200; 15.4uM; HL60; HT_HG-U133A	TNIK KIF13B SYNM SIPA1L3 NDRG3 SIPA1L1 PARD3	1.75e-04	195	136	7	3137_DN
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A	SETD1A SP1 TEP1 ADARB1 RUSC2 LRP6 LSM14A	1.75e-04	195	136	7	4117_DN
Drug	Oxethazaine [126-27-2]; Up 200; 8.6uM; PC3; HG-U133A	SH3TC2 PGS1 SRC RUSC2 CDC27 MTDH ZNF292	1.75e-04	195	136	7	1903_UP
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A	TNIK SETD1A SIPA1L3 RAB11FIP1 CCDC88A CUZD1 TOR1AIP1	1.75e-04	195	136	7	3721_DN
Drug	colchicine; Down 200; 1uM; SKMEL5; HG-U133A	HDAC6 TNRC6B RXRA CCDC88A PAPOLA PARD3 CDC27	1.75e-04	195	136	7	630_DN
Drug	Methylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; HL60; HT_HG-U133A	SP1 FN1 ANK3 EFNB2 PIK3CD SIPA1L1 HERC4	1.80e-04	196	136	7	3040_DN
Drug	Piperidolate hydrochloride [129-77-1]; Down 200; 11.2uM; MCF7; HT_HG-U133A	SETD1A BCORL1 AOX1 FBXO38 NCOR1 UBAP2L PARD3	1.80e-04	196	136	7	6772_DN
Drug	Parbendazole [14255-87-9]; Up 200; 16.2uM; PC3; HT_HG-U133A	TNIK SP1 ACRV1 EFNB2 AGFG1 NAV2 MUC5AC	1.80e-04	196	136	7	4535_UP
Drug	Flucloxacillin sodium [1847-24-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A	KIF13B EPN2 ARNT PIK3CD SIPA1L1 LRP6 TOR1AIP1	1.86e-04	197	136	7	6507_DN
Drug	Naphazoline hydrochloride [550-99-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A	SP1 AMBRA1 ADARB1 PCDH17 LRP6 PARD3 HERC4	1.86e-04	197	136	7	4949_UP
Drug	Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; MCF7; HT_HG-U133A	SP1 HDAC6 ABI3BP SIPA1L3 EPN2 RUSC2 SIPA1L1	1.86e-04	197	136	7	5436_DN
Drug	Prochlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; MCF7; HT_HG-U133A	CAMK2B SIPA1L3 SRC CRTC1 EPN2 NCOR1 ARNT	1.86e-04	197	136	7	2641_DN
Drug	genistein; Down 200; 10uM; MCF7; HT_HG-U133A_EA	SYNM ABCC5 BCL9 NPHP4 SIPA1L1 HERC4 TOR1AIP1	1.86e-04	197	136	7	1015_DN
Drug	Alcuronium chloride [15180-03-7]; Down 200; 5.4uM; MCF7; HT_HG-U133A	SP1 AOX1 EPN2 FBXO38 ARNT UBAP2L ZNF292	1.86e-04	197	136	7	7345_DN
Drug	5194442; Down 200; 20uM; MCF7; HT_HG-U133A	HIVEP2 AOX1 ARNT NAV2 LRP6 LSM14A HERC4	1.86e-04	197	136	7	6558_DN
Drug	pioglitazone HCl; Down 200; 10uM; MCF7; HT_HG-U133A	SETD1A HIVEP2 CLASP2 NCOR1 ARNT PAPOLA FBXO41	1.86e-04	197	136	7	7523_DN
Drug	Butirosin disulfate salt [51022-98-1]; Down 200; 5.4uM; HL60; HT_HG-U133A	SIPA1L3 NDRG3 FBXO38 PAPOLA SIPA1L1 LRP6 ZMYM6	1.86e-04	197	136	7	2518_DN
Drug	Lansoprazole [103577-45-3]; Down 200; 10.8uM; MCF7; HT_HG-U133A	SP1 ABI3BP SRC BCORL1 RUSC2 NAV2 PARD3	1.86e-04	197	136	7	3529_DN
Drug	Amiloride hydrochloride dihydrate [17440-83-4]; Down 200; 13.2uM; MCF7; HT_HG-U133A	SP1 HIVEP2 SIPA1L3 ADCY9 PAPOLA PARD3 DNAJB2	1.86e-04	197	136	7	1470_DN
Drug	Minaprine dihydrochloride [25953-17-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A	SP1 SYNM EPN2 NCOR1 ARNT PAPOLA FBXO41	1.86e-04	197	136	7	1468_DN
Drug	Dimenhydrinate [523-87-5]; Down 200; 8.6uM; PC3; HT_HG-U133A	TNIK SH3TC2 SRC BCL9 RUSC2 FBXO38 CCDC88A	1.92e-04	198	136	7	6352_DN
Drug	Imidurea [39236-46-9]; Up 200; 10.4uM; PC3; HT_HG-U133A	SETD1A FN1 NPHP4 ADCY9 ARNT PIK3CD MUC5AC	1.92e-04	198	136	7	5062_UP
Drug	Loxapine succinate [27833-64-3]; Up 200; 9uM; MCF7; HT_HG-U133A	KIF13B ADARB1 EPN2 TENM4 TBR1 MUC5AC ZMYM6	1.92e-04	198	136	7	1516_UP
Drug	Clindamycin hydrochloride [21462-39-5]; Up 200; 8.6uM; PC3; HT_HG-U133A	TPR SETD1A BCORL1 TEP1 TENM4 LSM14A ZMYM6	1.92e-04	198	136	7	2057_UP
Drug	Noscapine [128-62-1]; Down 200; 9.6uM; MCF7; HT_HG-U133A	FN1 BCORL1 AOX1 SAV1 CLASP2 RXRA UBAP2L	1.92e-04	198	136	7	7204_DN
Drug	Sulfanilamide [63-74-1]; Down 200; 23.2uM; MCF7; HT_HG-U133A	KIF13B SP1 SIPA1L3 SAV1 ARNT LSM14A ZNF292	1.92e-04	198	136	7	3449_DN
Drug	Artemisinin [63968-64-9]; Down 200; 14.2uM; MCF7; HT_HG-U133A	BCORL1 AMBRA1 EPN2 ARNT SIPA1L1 FBXO41 TOR1AIP1	1.92e-04	198	136	7	7007_DN
Drug	Proguanil hydrochloride [637-32-1]; Up 200; 13.8uM; MCF7; HT_HG-U133A	FLG PHF8 BCL9 TEP1 CCDC88A PAPOLA MUC5AC	1.92e-04	198	136	7	3505_UP
Drug	Apramycin [37321-09-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A	KIF13B BCORL1 AOX1 TNRC6B CLASP2 ADCY9 ARNT	1.92e-04	198	136	7	7334_DN
Drug	estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A	HIVEP2 FN1 SIGLEC8 SRC AOX1 CRTC1 BCL9	1.92e-04	198	136	7	6957_UP
Drug	Ketoconazole [65277-42-1]; Down 200; 7.6uM; MCF7; HT_HG-U133A	KIF13B HIVEP2 CAMK2B AOX1 CLASP2 EPN2 NCOR1	1.92e-04	198	136	7	2640_DN
Drug	Iodixanol [92339-11-2]; Down 200; 2.6uM; HL60; HT_HG-U133A	SETD1A ANK3 PHF8 EPN2 ARNT CCDC88A TBR1	1.92e-04	198	136	7	3023_DN
Drug	Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; MCF7; HT_HG-U133A	SETD1A BCL9 NDRG3 FBXO38 UBAP2L CUZD1 LRP6	1.92e-04	198	136	7	5304_UP
Drug	Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Up 200; 6.4uM; MCF7; HT_HG-U133A	SETD1A SRC AOX1 CRTC1 TECTA TEP1 TENM4	1.92e-04	198	136	7	7011_UP
Drug	Rimexolone [49697-38-3]; Up 200; 10.8uM; MCF7; HT_HG-U133A	SETD1A SNED1 TENM4 PAPOLA SIPA1L1 FBXO41 TBR1	1.98e-04	199	136	7	3516_UP
Drug	Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; MCF7; HT_HG-U133A	SP1 ANK3 NDRG3 EPN2 FBXO38 PAPOLA TOR1AIP1	1.98e-04	199	136	7	1500_DN
Drug	Methazolamide [554-57-4]; Down 200; 17uM; MCF7; HT_HG-U133A	GATB TNRC6B AMBRA1 NPHP4 RXRA NCOR1 LRP6	1.98e-04	199	136	7	6268_DN
Drug	Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A	HDAC6 SAV1 AMBRA1 PHF8 EPN2 LSM14A HERC4	1.98e-04	199	136	7	3403_DN
Drug	Molsidomine [25717-80-0]; Down 200; 16.6uM; MCF7; HT_HG-U133A	ABI3BP NCOR1 UBAP2L SIPA1L1 PARD3 HERC4 ZMYM6	1.98e-04	199	136	7	5426_DN
Drug	Fenbufen [36330-85-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A	TNIK FN1 CAMK2B SRC ARNT HERC4 CD96	1.98e-04	199	136	7	3618_UP
Disease	Psychotic Disorders	SP1 ANK3 BCL9 ADARB1 TENM4 PTPRC	8.26e-06	101	138	6	C0033975
Disease	cortical surface area measurement	TNIK PALD1 SP1 ANK3 TNRC6B PERM1 FAM117B ARHGAP39 NCOR1 CCDC88A EFNB2 ARHGAP31 PIK3CD SPATA16 AGFG1 NAV2 KIAA1755 IGSF9 PARD3	1.70e-05	1345	138	19	EFO_0010736
Disease	Intellectual Disability	CACNA1E SETD1A HIVEP2 CAMK2B KMT2E BPTF MED12L EIF2A ZMYM6 ZNF292	5.07e-05	447	138	10	C3714756
Disease	keratoconjunctivitis (is_marker_for)	MUC16 MUC5AC	6.49e-05	3	138	2	DOID:9368 (is_marker_for)
Disease	Neurodevelopmental Disorders	TNRC6B KMT2E SMC3 TBR1 ZNF292	7.77e-05	93	138	5	C1535926
Disease	high affinity immunoglobulin gamma fc receptor i measurement	IGLV3-25 IGLV3-22	1.29e-04	4	138	2	EFO_0020447
Disease	Sjogren's syndrome (is_marker_for)	MUC19 MUC16 MUC5AC	1.89e-04	24	138	3	DOID:12894 (is_marker_for)
Disease	cholangiocarcinoma (is_marker_for)	HDAC6 MUC16 MUC3A MUC5AC	2.34e-04	64	138	4	DOID:4947 (is_marker_for)
Disease	Schizophrenia	TNIK SETD1A SP1 DRD3 ANK3 CAMK2B AMBRA1 BCL9 ADARB1 PCDH17 TENM4 EFNB2 SLC6A5	2.67e-04	883	138	13	C0036341
Disease	Nonorganic psychosis	SP1 ANK3 TENM4 PTPRC	3.13e-04	69	138	4	C0349204
Disease	metabolic syndrome	PGS1 CAMK2B HECTD4 BPTF ARNT POC5	3.68e-04	200	138	6	EFO_0000195
Disease	serum gamma-glutamyl transferase measurement	TNIK SEMA4B IFT172 SIPA1L3 HECTD4 PERM1 POM121C BPTF POM121 TENM4 NAV2 PARD3 ZNF292	3.72e-04	914	138	13	EFO_0004532
Disease	Prostatic Neoplasms	HDAC6 AOX1 FOXA3 RXRA NCOR1 PTPRC PIK3CD PARD3 CDC27 ZNF292	6.63e-04	616	138	10	C0033578
Disease	Malignant neoplasm of prostate	HDAC6 AOX1 FOXA3 RXRA NCOR1 PTPRC PIK3CD PARD3 CDC27 ZNF292	6.63e-04	616	138	10	C0376358
Disease	Nephronophthisis	IFT172 NPHP4	7.65e-04	9	138	2	cv:C0687120
Disease	dry eye syndrome (is_marker_for)	MUC16 MUC5AC	9.53e-04	10	138	2	DOID:10140 (is_marker_for)
Disease	reaction time measurement	TNIK HECTD4 MUC19 GATB AMBRA1 RXRA PCDH17 POM121 NAV2 CDC27	1.09e-03	658	138	10	EFO_0008393
Disease	Fetal Alcohol Spectrum Disorders	ANK3 OTX2	1.64e-03	13	138	2	C2985290
Disease	Neoplasm Invasiveness	SP1 UBQLN1 FN1 SRC MTDH	1.77e-03	184	138	5	C0027626
Disease	RS-10-hydroxywarfarin to RS-warfarin ratio measurement	TNIK TENM4 SIPA1L1 MUC3A	1.80e-03	110	138	4	EFO_0803335
Disease	polycystic kidney disease (implicated_via_orthology)	HDAC6 IFT172	1.90e-03	14	138	2	DOID:0080322 (implicated_via_orthology)
Disease	cortical thickness	TNIK PALD1 SP1 TNRC6B PCDH17 CCDC88A EFNB2 SPATA16 NAV2 KIAA1755 IGSF9 LSM14A PARD3	2.22e-03	1113	138	13	EFO_0004840
Disease	Abnormal behavior	BCORL1 MED12L	2.50e-03	16	138	2	C0233514
Disease	urate measurement, spine bone mineral density	SH3TC2 SRC NAV2	2.56e-03	58	138	3	EFO_0004531, EFO_0007701
Disease	retinopathy	SRC TENM4	2.82e-03	17	138	2	EFO_0003839
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	RFX7 ZNF292	2.82e-03	17	138	2	DOID:0060307 (is_implicated_in)
Disease	Fetal Alcohol Syndrome	ANK3 OTX2	2.82e-03	17	138	2	C0015923
Disease	pancreatic ductal carcinoma (is_marker_for)	RXRA MUC3A MUC5AC	2.95e-03	61	138	3	DOID:3587 (is_marker_for)
Disease	Child Behaviour Checklist assessment	TENM4 SPATA16	3.16e-03	18	138	2	EFO_0005661
Disease	Myeloid Leukemia	KMT2E SMC3	3.16e-03	18	138	2	C0023470
Disease	Leukemia, Monocytic, Chronic	KMT2E SMC3	3.16e-03	18	138	2	C0023466
Disease	Tinnitus	GATB TNRC6B SIPA1L1 BAIAP2L2	3.30e-03	130	138	4	HP_0000360
Disease	lymphocyte count	TNIK PALD1 SH3TC2 FN1 HECTD4 TNRC6B ABCC5 RFX7 ADCY9 NCOR1 TENM4 PTPRC ARHGAP31 PIK3CD MED12L	3.61e-03	1464	138	15	EFO_0004587
Disease	Seizures	CACNA1E DRD3 KMT2E MED12L ZNF292	3.68e-03	218	138	5	C0036572
Disease	brain measurement, neuroimaging measurement	TNIK ANK3 DSCAML1 BPTF NAV2 KIAA1755 IGSF9 PARD3	4.45e-03	550	138	8	EFO_0004346, EFO_0004464
Disease	cardiomyopathy (implicated_via_orthology)	ASAH2 GATB TBX20	4.54e-03	71	138	3	DOID:0050700 (implicated_via_orthology)
Disease	cigarettes per day measurement	SETD1A ZNF618 AMBRA1 POM121C ADARB1 PCDH17 SIPA1L1	4.65e-03	438	138	7	EFO_0006525

Protein segments in the cluster

Peptide	Gene	Start	Entry
PTTRSGFSAQQVATQ	ARNT	641	P27540
RTSQFGVGSFQTPSS	ARNT	661	P27540
NRQGTGSLSESSIPS	CACNA1E	2131	Q15878
GTEQQTEGTSVTFSP	BCORL1	586	Q5H9F3
GDGSDVSSQTPQTSS	ANKIB1	1066	Q9P2G1
PTGSTSNQIRGESSV	GATB	31	O75879
SGPRTSRNQGSSVSQ	FLG	1906	P20930
SAGPRTSRNQGSSVS	FLG	3526	P20930
NRPSAFSTVQSSTAG	AMBRA1	366	Q9C0C7
NDSSAQSVSSGVRAP	ANKRD17	2386	O75179
GIIPSSTGTSQQTFT	BPTF	2136	Q12830
STGTSQQTFTSFQPR	BPTF	2141	Q12830
ARGTSSQPNELSGSI	ACRV1	16	P26436
TTSTDLVQPASGGSF	AMPH	386	P49418
STETVPNANISGGSV	AOX1	1076	Q06278
FTGQGTNASETPATR	PCDH17	836	O14917
QSISTSVGPSASQRN	RAB2B	191	Q8WUD1
AQFESSRQSRSGVPS	ARHGAP39	661	Q9C0H5
STAQQTVSAGTPFEG	PALD1	6	Q9ULE6
IPERFSGSNSGNTAT	IGLV3-1	76	P01715
IPERFSGSSSGTTVT	IGLV3-25	76	P01717
AGSSTPGRTSQFVDT	MUC16	1091	Q8WXI7
VNGFTQRSSVPTTST	MUC16	13281	Q8WXI7
LGSGESPFSRSVTSN	NDRG3	336	Q9UGV2
SPFSRSVTSNQSDGT	NDRG3	341	Q9UGV2
STRNNSGFTPADTVA	SLC10A7	256	Q0GE19
PVVQNDSSRGSSVSS	POC5	11	Q8NA72
FNPNSIGSADTSSTR	MED12L	1381	Q86YW9
FSQGLSSTVQSRTDP	MAGEB3	96	O15480
SVQGPSGTQSFRRSG	HSFX4	231	A0A1B0GTS1
QSQVPRLTGGSFSSE	KIAA1755	1166	Q5JYT7
ITFGRGSSQPNLSTS	EPN2	166	O95208
ASQSISGVPSRFSGS	IGKV6D-41	71	A0A0C4DH26
PATQGSTAAQRSTAT	ASAH2	56	Q9NR71
GSAQSSRSNSFGERP	BAIAP2L2	306	Q6UXY1
SAGIQTSFRTGNPTG	DDX5	551	P17844
TRRQGFTSVPSQGGS	CSRNP3	76	Q8WYN3
SPQGVSDDSSTGSRV	CCDC88A	1566	Q3V6T2
EAGTNGRSSTTSPFV	EFNB2	186	P52799
TGVTTGTTLAPRSFN	MUC19	6161	Q7Z5P9
PGNNNTEATSSTRGV	MUC19	6726	Q7Z5P9
SGTRVTPGSSNSEAT	MUC19	7141	Q7Z5P9
GVVSGNTISPSSFNT	MUC19	7911	Q7Z5P9
NTISPSSFNTEATSG	MUC19	7916	Q7Z5P9
VSTTGRGQTTFPSST	MUC3A	966	Q02505
GTGTVPTNTVFTSTR	MUC3A	2851	Q02505
SGVVSSATFEQPSRQ	PGS1	526	Q32NB8
QLGTGSTSNRKSPFT	HERC4	326	Q5GLZ8
GTLFTQTPSGQSSAT	KMT2E	1516	Q8IZD2
GSQGFTVVVSSVPSQ	LRP6	996	O75581
IPERFSGSNSGNTAT	IGLV3-21	76	P80748
FGTETSNSGTLPQSS	LSM14A	146	Q8ND56
TATSRGGPTATSVTQ	MUC5AC	2091	P98088
RSPDSNNVASSAVGT	HECTD4	2341	Q9Y4D8
TSTFQGAGTTEPADR	ADARB1	496	P78563
SVQGPSGTQSFRRSG	HSFX3	231	A0A1B0GWH4
VVGTQTRSSAGQPSR	NPHP4	581	O75161
REFTTAVSSPGGQSV	IFT172	241	Q9UG01
GQSTPFAFNVGSTTE	POM121C	1136	A8CG34
GQSTPFAFNVGSTTE	POM121B	741	A6NF01
VSVPQVNSSESSGGT	PAPOLA	576	P51003
IPERFSGSTSGNTTT	IGLV3-22	76	A0A075B6J6
STNTRSSGVPDRFSG	IGLV8-61	76	A0A075B6I0
GQSTPFAFNVSSTTE	POM121	1156	Q96HA1
ASQSPDFVRTVNSGG	FBXO38	721	Q6PIJ6
DFVRTVNSGGSSEPS	FBXO38	726	Q6PIJ6
QGSGNTTVTRGNETS	ABCC5	886	O15440
STYRIPVQASGTGST	HYDIN	891	Q4G0P3
QTPFQSSGLDTSRTT	CRTC1	81	Q6UUV9
RAGTGPSSSEINATT	DSCAML1	1071	Q8TD84
VQTTSSGSGPFTDVR	FN1	276	P02751
SVTSRSGGTQVQQTP	DNAJB2	226	P25686
SSSTRSIDTQTPGGA	FAM117B	386	Q6P1L5
NRAVTPVSQGSNSSS	BCL9	311	O00512
GISSGSSPRVSSQDT	CCDC166	381	P0CW27
STETRSLPGETQSQG	GCM1	186	Q9NP62
SRQEPSQGTTTFAVT	IGHA1	281	P01876
PSVTIGRNSSQGSVD	FOXK1	121	P85037
TPVSGRGDSSNLTAT	ADCY9	196	O60503
TSLSETSRGGQPSVT	ANK3	4036	Q12955
TGASSRVPAASQSSG	FBXO41	401	Q8TF61
FSGIGSTAEPVSQST	MTDH	346	Q86UE4
PQVTATFTVSGGTAQ	KLHDC7B	546	Q96G42
ASTLQSGVPSRFSGS	IGKV1-8	71	A0A0C4DH67
QSTPRNTVSQSISGD	EIF2A	516	Q9BY44
GQVCGRVTPTFESSS	CUZD1	226	Q86UP6
VRNTTSTGLQFPASG	FCRLB	331	Q6BAA4
SFGEESTPGQTNSET	HDAC6	886	Q9UBN7
FSTQVNSSLTSPTGR	RXRA	11	P19793
SVFSQSGNSREVTPI	CDC27	331	P30260
LGTGQQTPSTSARAE	PERM1	96	Q5SV97
SGGTTALRPSASTQA	DDB1	746	Q16531
NISSGPESNTTGITA	TACR2	11	P21452
GFNTTGDPTVCSISN	DRD3	171	P35462
GANVESFSSSTRPGQ	LGSN	251	Q5TDP6
IPERFSGSNSGNTAT	IGLV3-9	76	A0A075B6K5
ASAPQNVFSTTVSSG	PARD3	436	Q8TEW0
DFVVTDTVPGSQSNS	PELI1	111	Q96FA3
SPAREVSSESGTSGQ	OTX2	116	P32243
TRTFVNGSSVSSPIQ	KIF13B	511	Q9NQT8
IEGSRFPRGSSNSSS	RUSC2	1286	Q8N2Y8
TRNFSVGRQTTAPAT	CAMK2B	311	Q13554
QASVTAPSEQTTEFG	RAB11FIP1	1036	Q6WKZ4
GFNSSDTVTSPQRAG	SRC	66	P12931
ESERGSGSQSSVPSV	SMC3	1076	Q9UQE7
SGSQSSVPSVDQFTG	SMC3	1081	Q9UQE7
GTEDTSQPGRVQTFT	TBR1	346	Q16650
ATVEVSSPTGFAQSQ	SYNM	1101	O15061
VPRSASTGAQTFQSA	SLC6A5	51	Q9Y345
IPERFSGSSSGTTVT	IGLV3-27	76	P01718
RNGTGSAASTTTPAA	FOXA3	231	P55318
RPSVFQGTNGTSVIT	NCOR1	1771	O75376
SVTSPSGTRFNFSQL	NAV2	1556	Q8IVL1
TVSSFQGNDPAISRS	SEMA4B	206	Q9NPR2
QAGSTPLTRENSTFS	SIPA1L1	1401	O43166
NVSFSRASVGSPSSG	SIPA1L3	441	O60292
QNEGTGTSRPVSQVT	SIGLEC8	346	Q9NYZ4
KSTSSGQVGFVPTRN	SH3TC2	311	Q8TF17
RSTQLNGSFPASSGV	SPATA16	441	Q9BXB7
ISSSGSQESGSQPVT	SP1	286	P08047
SQESGSQPVTSGTTI	SP1	291	P08047
SSGTNSQGQTPQRVS	SP1	346	P08047
SSRQDTPSSFGQFTP	SETD1A	251	O15047
GGSSSSPVNTFQTVL	SNED1	161	Q8TER0
STSNASSNVFGTVPV	AGFG1	396	P52594
RERTETPSGSSSGNN	CFAP20DC	246	Q6ZVT6
TANPSTVAGRVSAGS	CLASP2	341	O75122
ARSFSDSSPQTIQGG	PNMA5	371	Q96PV4
GGSSTTPVNTFQAVL	TECTA	156	O75443
SPNAFSTSGDVVSRN	SAV1	56	Q9H4B6
SQPGSQAGSSERTRV	TNIK	746	Q9UKE5
ATQTQTFRTPNSGSP	ZNF618	341	Q5T7W0
QTGLFRSSSGSGVQP	USP45	516	Q70EL2
LGNQSPSTSSRQVTG	TOR1AIP1	311	Q5JTV8
NTGVSVTSSNTGVPD	UBAP2L	966	Q14157
QTGSGQRSQTSSIPQ	UBAP2L	1056	Q14157
ARAFSEVPTTANGST	CD96	486	P40200
SSSPTAVAFSTNGQR	TEP1	1676	Q99973
TPFTQTSDLQRSSGF	SPEM3	786	A0A1B0GUW6
FGSTSGSVRSTSPNV	TPR	1741	P12270
SNTSSGEGSQPSRTE	UBQLN1	301	Q9UMX0
PRSGVTNFNTSVSQE	ZNF292	1471	O60281
SNSSRVSVISGPQNT	ZNF292	1601	O60281
TGTVRSNPNTDSAAA	PIK3CD	456	O00329
GRLTNVTFPTGQVSS	TENM4	1701	Q6N022
VTFPTGQVSSFRSDT	TENM4	1706	Q6N022
FGVFTTQTNSIPGSA	SEMA6C	316	Q9H3T2
PFSSSSSSGDIQGRN	USF3	1896	Q68DE3
SSSGDIQGRNTSPNV	USF3	1901	Q68DE3
NGSVVSLQSPGSRSS	RFX7	416	Q2KHR2
RSQEGPSSTSGTTQK	ARHGAP31	1231	Q2M1Z3
GSFVSDPSNTANVST	IGSF9	701	Q9P2J2
STNGPVSQEAFSVTG	ZNF598	406	Q86UK7
FSTGTGSQSVERTKP	WASHC2A	1136	Q641Q2
GNTSAVSPSSIRGSA	ZMYM6	391	O95789
SGLGTVSNSPASQRT	PHF8	796	Q9UPP1
DESQTTPNRGSAFTT	TBX20	326	Q9UMR3
AQGPGTSNSASRTTL	TMC2	851	Q8TDI7
GEGPVSNTVAFSTES	ABI3BP	911	Q7Z7G0
FESTGTGLSRSPSQE	HIVEP2	956	P31629
VRQASFSGSPEISQG	HIVEP2	1081	P31629
QTPSAGTDTQTFSGS	PTPRC	116	P08575
SGTIVRSQTFSPGAR	WWC3	901	Q9ULE0
QTGTPGTTAVSSNRN	nan	131	Q8N7P7
GNTSRSTDAPSQSTG	TNRC6B	401	Q9UPQ9
TLSPAGSTTRQGEST	MUC12	761	Q9UKN1
TLSPAGSTTRQGEST	MUC12	1816	Q9UKN1
VGEESTTSRSQPGST	MUC12	2351	Q9UKN1
SSTSPGLQGESTTFQ	MUC12	2681	Q9UKN1
PAGSTTRQGESTTFQ	MUC12	3376	Q9UKN1
TLSPAGSTTRQGEST	MUC12	4456	Q9UKN1